Table Of Content

Banerjee D, 1269 Braakhuis BJ, 530 Chodak GW, 139 Barista I, 51, 838 Bradlow H, 617 Choe KJ, 1317 AUTHOR Barnett JB, 1369 Brandt B, 1594 Choi G, 519 Barnhart S, 1550 Brants HAM, 93 Chou CM, 1000 Barnhill RL, 17 Brash DE, 349 Chow W-H, 1472 INDEX Baron JA, 1848 Brassure JR, 340 Chrismon JH, 1158 Barrett MJ, 1560 Brawley OW, 812 Chu KC, 1571 Barrett RJ, 1127 Breant C, 1315 Chung LW, 794 Barry MJ, 166 Brennan JA, 1580 Chung W-K, 1308 Bartnitzke S, 1234 Brinton LA, 1127 Ciardiello F, 1770 Bartsch D, 680 Brodkin CA, 1550 Cirillo PM, 1867 Basik M, 1665 Brotchi J, 594 Citro G, 419 A Bast RC, 1456 Brown CC, 123 Clark L, 81 Bastert G, 1652 Brown CJ, 480 Clark RM, 1659 Baty BJ, 872 Brown KK, 1046 Clarke R, 1821 Abbruzzese JL, 462 Baty JD, 1676 Brownlee HA, 552 Cleary KR, 1146 Abbruzzese MC, 462 Bazzoli F, 465 Broxterman HJ, 466 Clerici E, 461 Abrams J, 759 Beaty TL, 536 Brubaker A, 817 Clerici M, 461 Adami H, 727, 883, 1216, Beauchamp AE, 44 Brunda MJ, 38 Cloos J, 530 1302, 1472, 1864 Beecher G, 1513 Bryant J, 1529 Cochran CJ, 552 Adér HJ, 1478 Beemsterboer PMM, 54 Bryant JL, 450 Cofer KF, 510 Aickin M, 81 Begg CB, 17 Bucana CD, 1146 Cohen LA, 899 Aikou T, 1110 Behrens A, 980 Buckley JD, 1483 Cohen RD, 1867 Akiba S, 1110 Beijnen JH, 994 Buckwalter CA, 734 Cohn BA, 1867 Akiyama S, 1110 Bellapravalu S, 81 Buer J, 590 Colavito EA, 612 Akova M, 51 Bellefleur J, 55 Buller MK, 81 Colditz GA, 359, 365, 988, Akre O, 727, 883 Benasso M, 583 Bullerdiek J, 1234 1375 Albanes D, 1560 Benito J, 1320 Burger RA, 1361 Cole BF, 223, 1039, 1686 Albeck M, 1276 Bennett WP, 52 Burk RD, 781 Collette L, 890 Alberg AJ, 32, 1408 Benson A, III, 668 Burke HB, 1864 Colnaghi MI, 1002 Alberts DS, 81 Bentzen SM, 918 Burt ME, 193 Colomer R, !320 Albertsen PC, 166, 1177 Berchuck A, 552 Burton HS, 270 Comstock GW, 32 Alexander FE, 54 Berg CD, 759 Buyse M, 252 Conlon KC, 44 Alfthan G, 1408 Bergh J, 173, 1499, 1500 Buzaid AC, 569 Conversano L, 550 Allen-Mersh T, 252 Bergstrém R, 727, 1216, 1302, Cook JM, 908 Alvarez A, 198 1864 Cc Cook J, 1399 Alvarez-Sala R, 303 Berman ML, 1127, 1361 Cook LS, 210 Alvord WG, 44 Berne C, 1472 Cortina R, 279 Anand A, 838 Bernstein ID, 1483 Calabretta B, 419 Corvo R, 583 Anand A, 838 Berrino F, 291 Callery MP, 680 Costa SD, 1652 Anand N, 838 Berry DA, 1606 Camalier R, 259, 1161 Costantino J, 1529 Anderson GR, 1665 Bertino JR, 1269 Camby I, 594 Coté TR, 675 Anderson M, 193 Berwick M, 17 Cangiano C, 550 Courtney M, 1857 Anderson T, 668 Bettinger L, 81 Cao S, 430 Creekmore SP, 44 Andremont A, 1857 Bianco AR, 1770 Cardenal F, 1078 Cremona O, 442 Angeli A, 442 Bianco C, 1770 Carillo B, 303 Croyle RT, 872 Anton-Culver H, 1361 Bianco R, 1770 Carlson R, 252 Cullen MR, 1550 Anzano MA, 123 Biela BH, 510 Casalini P, 1002 Culp J, 607 Aprelikova O, 1489 Bilim V, 686 Cascinelli N, 1002 Curti BD, 44 Arcuri T, 1494 Bishop JF, 1297 Case LD, 1670 Curtis RE, 52, 832, 1497 Ardelt W, 747 Black WC, 627 Casillas M, 303 Ariniello PD, 1136 Blaser MJ, 465, 763 Cassaro M, 762 D Aristizabal N, 1068 Bleiker EMA, 1478 Castellsagué X, 1060, 1068 Aromaa A, 1408 Blengio F, 583 Castrén O, 966 Ascunce N, 1060 Bleyer WA, 375, 377 Catane R, 1276 D’ Agnano I, 419 Askin FL, 1560 Blinson K, 1670 Celik I, 51, 838 Daigneault-Creech CA, 1483 Assmann G, 1594 Boehm DK, 463 Cella DF, 661 Daling JR, 210, 1421 Asumendi A, 198 Boente MP, 1810 Cennerazzo WJ, 1686 Dallmann I, 590 Atkins CD, 303, 1496 Boer R, 54 Chaney SG, 1346 Daly MB, 1810 Atwood J, 81 Boice JD, Jr, 52, 832, 1497 Chang A, 252 Damiano V, 1770 Atzpodien J, 590 Boivin, J-F, 209 Chang S-M, 794 Danguy A, 594 Auvinen A, 966 Bolelli G, 291 Chao Y, 1000 Datia RS, 556 Avril N, 1204 Bonelli L, 583 Chatenoud L, 1003 Davis S, 542 Boniver J, 824 Chen C-L, 1840 Davis S, 1670 B Bontenbal M, 1393 Chen H-H, 52 DeBord DG, 1046 Borst P, 994 Chen LT, 1000 de Castro J, 303 Bosch FX, 1060, 1068 Chen TL, 817 DeCillis A, 1529 Bacchetti S, 1152 Bosq J, 1228 Chen YM, 1000 Decher L, 842 Back TC, 38 Bostwick DG, 1686 Cheng L, 607 DeCosse JJ, 1686 Balch CM, 569 Botkin JR, 872 Cheng PC, 510 Defresne MP, 824 Baldeyrou P, 1857 Bourhis J, 1228 Cherniack MG, 1550 De Giovanni C, 926 Bale AE, 349 Bowling K, 817 Chevalier D, 890 De Giuli F, 465 Ballard-Barbash R, 716 Bowman DM, 1529 Chiesa G, 1242 Dr Giuli M, 1000 Balmes J, 1550 Boyd J, 1408 Cho E, 1821 de Koning HJ, 52, 54 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 AUTHOR INDEX 1873 Delvenne P, 824 Figueroa JA, 601 Gonzalez LC, 1060 Hendriks JHCL, 1478 Deleyiannis FW, 542 Fine JA, 17 Goodfellow PJ, 680 Hennekens CH, 1118 Deman J, 824 Fine RL, 908 Goodman GE, 1550 Henson DE, 1015 de Placido S, 1770 Firat D, 838 Goodman SN, 1580 Herndon JE, II, 661, 1210 De Rossi M, 442 Fishel R, 1608 Goodwin JS, 1031 Hertog MGL, 93 de Sanjosé S, 1060 Fisher B, 1529 Goos M, 802 Hertzmark E, 1369 Desch CE, 1456 Fisher ER, 1529 Gorbach SL, 1369 Herz M, 1204 Deschénes L, 1529 Fisher MC, 109 Gorlick R, 1269 Hess KR, 462 Devesa SS, 298 Fitzsimmons SA, 259, 1161 Gosewehr JA, 510 Heston WDW 57 de Villiers EM, 802 Fletcher SW, 627 Graeff H, 1204 Heyne K, 519 de Wit R, 1393 Flick BJ, 872 Graham CH, 1285 Hicks DJ, 1731 Diel IJ, 1652 Fogler WE, 747 Graham S, 340 Hidalgo M, 1320 Dignam J, 1529 Folkman J, 10°1 Grauman D, 298 High JL, 812 Dignan M, 1670 Fontanini G, 1770 Gray R, 1828 Hilakivi-Clarke L, 1821 Dillman RO, 1210 Forastiere AA, 817, 855, 1580 Greco WR, 699 Hilsenbeck SG, 601 Di Mario F, 762 Ford L, 812 Green MR, 1210 Hirohata T, 742 Dimitrov NV, 1529 Forrest AP, 54 Green SB, 812 Hirvonen A, 1853 Dinarello CA, 198 Fox KR, 1076 Greenberg ER, 1848 Hittelman WN, 519 Ding I, 1399 Franceschi S, 1003 Greenwald P, 1560 Hiyama E, | 16, 839 Donehower RC, 734, 817 Franco JL, 38 Greimers R, 824 Hiyama K, 116, 839 Dorgan JF, 1127 Frank C, 430 Grever M, 259, 1161 Hochhauser D, 1269 Doroshow JH, 393, 1495 Fraumeni JF, Jr, 298, 612, 650, Grochow LB, 734, 817 Hochwald SN, 193 Dose J, 1204 832, 1472, 1497 Groshen S, 1495 Hodge T, 1240 Driver CL, 123 Freedman LS, 1560 Gross EG, 349 Hoffman SC, 32 Dubeau L, 510 Freudenheim JL, 340 Grosse J, 590 Hogan DJ, 56 Dubois I, 1228 Friedman MA, 812 Gruber J, 1436 Hogan WM, 1810 Duensing S, 590 Fritsche H, Jr, 1456 Guerrero E, 1060 Holland JC, 661 Duffy SW, 52 Fukuda M, 1240 Guffroy M, 1240 Holland JF, 661 Fulton AM, 536 Giillii I, 51 Holle R, 1652 E Funk A, 1222 Gupta J, 1152 Holmberg L, 173, 1216, 1500, Fuscoe JC, 1840 1864 Futreal PA, 552 H Holmlund JT, 44 Eastman A, 956 Heng W, 519, 567 Eaton WL, Jr, 1210 G Hoover RN, 650, 756, 1127 Edwards BK, 1560, 1571 Haapakoski J, 1560 Horn-Ross PL, 650 Egan KM, 988 Hahm H, 555 Hdrte LG, i28 Eisenberger MA, 779 Gailani MR, 349 Hakama M, 966, 1408 Hoskins WJ, 1790 Ekbom A, 727, 883, 1302, Gallie BL, 1152 Hakulinen T, 128 Houghton J, 1834 1472 Gallo O, 1865 Hakulinen T, 727, 1408 Hsieh C-C, 883 El-Mofty SK, 1676 Gallo RC, 450 Haldorsen T, 128 Hsing AW, 1093 Elledge RM, 141 Galloway DA, 1421 Haller DG, 668 Hsu TC, 530 Ellis LM, 1146 Gann PH, 1118 Hamilton TC, 1810 Huang K, 1399 Elwood JM, 3 Ganser A, 590 Hamm H, 802 Hubbert NL, 1467 Engeland A, 128 Ganz PA, 1315 Hammar S, 1550 Huber ML, 55 Engholm G, 1302 Garbers S, 617 Han C, 1467 Humblet C, 824 Ercikan-Abali E, 1269 Garte SJ, 617 Han H-J, 1317 Hunt WC, 1031 Eriksen MP, 841 Gause BL, 44 Han L-P, 1152 Hunter DJ, 1375 Erozan Y, 1560 Gautier E, 1857 Handelman GJ, 1513 Hunter NR, 13%8 Eschwege F, 1228 Gazdar AF, 116, 839 Hankey BF, 52, 832, 1497, Husgafvel-Pursiainen K, 1853 Escobedo LG, 841, 1158 Geiser T, 419 1571 Huttunen JK, 1560 Esper PS, 55 Gelber RD, 1039, 1686 Hansen RM, 668 Ettinger D, 817 Gelmann EP, 224 Hardy CR, 675 Evans AC, 552 Gerber M, 857 Harlan LC, 716 Evans J, 1529 Ghaffari AM, 1060, 1068 Harris CC, 315, 1442 Ghilchik M, 839 Harris EL, 754 Ignacio V, §!/ F Gibson J", 1748 Harrison LE, 193 Ikematsu H, ‘4. Gili M, 1060 Hartge P, 298, 612, 675 Ikuno N, 1240 Giordano D, 1494 Hartman AM, 1560, 1748 Imai T, 686 Faessel H, 699 Giovanella BC, 372 Hascall G, 1436 Inganiis M, 173, 1500 Falkson HC, 1828 Giovannucci EL, 988, 1375, Haughey BH, 1676 Ishikawa T, 466 Fan J, 1269 1717 Haustein U, 802 Izarzugaza I, 1060 Farinati F, 762 Giovino GA, 841 Hawkins MM, 270 Fan S, 956 Glass AG, 1550 Hayes DF, 1456 J Farrar WB, 1529 Glickman LT, 1686 Hayman JA, 1866 Faulkner DL, 1158 Glisson BS, 567 Hayran M, 51 Fears TR, 298 Godorov G, 510 Heijn M, 466 Jackson JG, 601 Feig SA, 683 Godwin AK, 1810 Heimann R, 1754 Jackson MJ, 536 Feldman MI, 1529 Goepfert H, 519 Heinonen OP, 1560 Jacobs TW, 1054 Felix JC, 510 Goldbohm RA, 93, 768 Hejna M, 1593 Jinicke F, 1204 Fenton RG, 44 Goldgar DE, 872 Helgesen F, 1216, 1864 Janik JE, 44 Ferguson D, 1764 Goldhirsch A, 1039, 1686 Hellman S, 1764 Jeffers S, 1079 Ferrarini M, 436, 1242 Goldstein AM, 1492 Heltai S, 436, 1242 Jeffers S, 1495 Feuer EJ, 1683 Gollahon L, 116, 839 Helzlsouer KJ, 32, 754, 1408 Jenkins NH, 840 Fidler IJ, 1700 Gémez L, 303 Henderson BE, 1332 Jessup JM, 1456 1874. AUTHOR INDEX Journal of the National Cancer Institute, Vol. 86, No. 24, December 18, 1996 Johansson J-E, 1216, 1864 Krzywda B, 668 Liu TW, 1000 Micheli A, 291 Johnson A, 661 Ku J-L, 1317 Liu W, 1146 Michielutte R, 1670 Johnson DH, 1175, 1866 Kuipers EJ, 465, 763 LiVolsi VA, 939 Miele ME, 1731 Johnson ES, 51 Kundu N, 536 Llort G, 1078 Mikulski SM, 747 Johnson K, 1495 Kung H-F, 747 Locker GY, 1456 Milas L, 1308 Johnston DA, 794 Kunter U, 590 Logsdon DL, 123 Miller BA, 1571 Jolitz G, 842 Kuo M, 467 Loken MR, 1483 Miller LL, 44 Jung EG, 802 Kuroi K, 116, 839 Lollini P-L, 926 Millward M3, 1297 Junker R, 1594 Kurosaki T, 1361 Longcope C, 1118, 1369 Milross CG, 1308 Longo DL, 44, 747 Miyadera K, 1110 K L Lorberboum-Galski H, 973 Moghimi SM, 766 Lowy DR, 1467 Mohner M, 727 Kadish AS, 781 Laderoute MP, 210, 1239 Lozupone F, 419 Mokbel K, 839 Kahlenberg MS, 1665 Lake AJ, 650 Lubejko B, 817 Monier R, 1857 Kalechman Y, 1276 Lambert JM, 1136 Lubin R, 1228 Monk BJ, 1361 Kang K, 1317 Lampkin B, 24 Luboinski B, 890, 1228 Montes A, 1078 Kang Y, 279 Lamy D, 1857 Lunardi-Iskandar Y, 450 Moore DE, 210 Kapitain S, 1285 Lancaster JM, 552 Luo P, 510 Morgando A, 1000 Kaplan GA, 1867 Landuzzi L, 926 Luostarinen T, 128 Morin GB, 1095 Karagas MR, 1848 Lane PR, 56 Lurain JR, 1127 Morris CR, 456 Karp JE, 407, 1787 Lange BJ, 1483 Lu-Yao GL, 166 Morris JS, 32 Kashiwagi S, 742 Lankelma J, 466 Lynch HT, 1810 Mortel R, 1127 Katagiri A, 686 Larson EB, 643 Lynn WR, 1748 Morton CG, 1297 Kataoka T, 116, 839 Laub PB, 1810 Mueller MD, 1748 Kaufman B, 1276 Laughlin R, 340 M Muggia FM, 1079, 1495 Kaufmann M, 1652 Lavasseur L, 699 Muise-Helmericks R, 1269 Kaufmann SH, 734 La Vecchia C, 1003 MaJ, 1118 Mukhtar H, 768 Kaul S, 1652 Lavergne D, 802 Maatela J, 1408 Mulieri M, 550 Kawakami Y, 100 Laviano A, 550 MacLennan R, 377, 378 Mullen LT, 123 Kawasaki T, 686 Lawrence TS, 1193 Macdonald JS, 1456 Mulloy WP, 686 Kazmierczak B, 1234 Laya MB, 643 Macrae F, 378 Mufioz N, 1060, 1068 Kelly WK, 1623 Le Cesne A, 1857 Mahmoud H, 1840 Murata F, 1110 Kemeny M, 252 Le Chevalier T, 1857 Mahoney LJ, 1659 Murphy LC, 284 Kemeny N, 252, 1456 Le Houillier C, 1136 Mikelainer I, 966 Murray JC, 766 Keogh JP, 1550 Lee AV, 601 Maksymiuk AW, 463 Muti P, 291 Kerbel RS, 1285 Lee DJ, 1580 Malila N, 1560 Kessler LG, 716, 1571, 1748 Lee JJ, 519 Manns A, 675 N Kiang DT, 661 Lee JS, 519 Marandas P, 1228 Kim C-Y, 13!7 Lee J-H, 1731 Marchisio PC, 442 Nagler A, 973 Kim C-S, 908 Lee KH, 1317 Margarino G, 583 Naik H, 55 Kim J-P, 1317 Lee M, 842 Margolese RG, 1529 Nakamura Y, 1317 Kim K-Y, 1317 Lefebvre J-L, 890 Marincola FM, 100 Nanni P, 926 Kim S, 1317 Leffell DJ, 349 Marsden HB, 270 Nash JE, 872 Kim TM, 510 Leichman L, 1495 Marshall JR, 340 Nathrath W, 1204 Kimball ES, 109 Leigh IM, 802 Martinez J, 594 Navarro C, 1060 Kirchner H, 590 Lenzi R, 462 Martinez M, 1375, 1717 Nayfield SG, 716 Kirkpatrick A, 890 Leonetti C, 419 Mason KA, 1308 Negri E, 1003 Kirn DH, 764 Lerman C, 872 Mason TJ, 612 Nekarda H, 1222 Kiss R, 594 Leung D, 1586 Mattson K, 1853 Nelson WG, 779 Kitadai Y, 1146 Levasseur L, 669 Mayne ST, 1513 Nemoto T, 340 Kiviat NB, 317 Leventon-Kriss S, 450 Mazumdar M, 1623 Neumann C, 802 Klokman WJ, 209 Levin B, 67 McAdams MJ, 612 Newman E, 1495 Knekt P, 1408 Levine M, 1659 McCaffrey RP, 407 Newmark H, 1586 Knutsson A, 1302 Levy E, 252 McCulloch P, 1659 Newton DL, 747 Koch WM, 1580 Lewis AD, 259, 1161 McDonald JA, 1848 Nicoletti G, 926 Kohn KW, 1255 Leygue ER, 284 McGinn CJ, 1193 Nicolson GL, 479 Kohno S, 1240 Li L, 1467 McGuigan KA, 1315 Nomura AM, 650 Kolonel LN, 650 Li W-W, 1269 McKnight B, 210 Nooijen WJ, 994 Komschilies KL, 38 Li Y, 1467 McLaughlin JK, 1472 Norberg T, 173, 1500 Konen J, 1670 Lichter AS, 1866 McQuellon RP, 1670 Nordgren H, 173, 1500 Kopecky KJ, 927 Lickley HL, 1529 Meguid MM, 550 Norkus EP, 32 Kopp WC, 44 Liippo K, 1560 Mehl S, 617 Norton JA, 680 Kornblith AB, 661 Linahan BM, 1297 Melton RG, 153 Norton L, 661, 1456 Kornek G, 1593 Lindgren A, 173, 1500 Ménard S, 436, 1002, 1242 Novakovic B, 1492 Kornfehl H, 1593 Linet MS, 1472 Mendelsohn J, 1770 Numico G, 583 Korzun A, 661 Linnainmaa K, 1853 Mendenhall WM, 1407 Nyrén O, 1302, 1472 Koscielny S, 1228 Lipa M, 1659 Mennel RG, 1456 Nystrém L, 1302 Koskinen K, 1853 Lipkin M, 1586 Merlano M, 583, 1407 Koutsky LA, 317 Lippman ME, 1821 Merrill RM, 1683 O Kramer A, 764 Lippman SM, 519 Merritt RK, 1158 Kramer BS, 1698 Lishner M, 973 Mesia R, 1078 Krogh V, 291 Litwin S, 462 Meuwissen SG, 465, 763 O’Brien ET, 908 Krook JE, 1039, 1686 Liu JM, 1000 Meyskens FL, Jr, 927, 1550 O’Connell M, 252 Kruit WH, 1393 Liu Q, 1840 Michaels FH, 372 O’Connor PM, 956 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 AUTHOR INDEX. 1875 O'Reilly S, 616, 817 Potischman NA, 756, 1127 Rookus MA, 1759 Sharma RK, 556 Ogden GR, 1864 Potok MHN, 270 Rose BR, 1331 Sharp P, 1670 Oh J-H, 1317 Potosky AL, 166, 716, 1683 Rose DM, 193 Shay JW, 116, 839 Oh N-G, 1317 Powers C, 1764 Rosenberg L, 941 Shearer GM, 461 Oka M, 1240 Powers GC, 44 Rosenberg SA, 100, 1635 Sheehan C, 1285 Okunieff P, 1399 Prados C, 303 Rosenblum N, 1810 Sherwood RF, 153 Olshan AF, 1489 Prentice RL, 1419, 1738 Rosner BA, 359, 365, 988 Shevlin DS, 680 Omenn GS, 1550 Pretlow TG, 607 Ross JA, 24 Shewach DS, 1193 Onojafe I, 1821 Preziosa I, 550 Rossi SC, 331 Shibata H, 1529 Opolon P, 1857 Price FM, 754 Rossi-Fanelli F, 550 Shin DM, 519 Oppenheim JJ, 44 Priebe W, 467 Rosso R, 583 Shin HJC, 519 Orlandi F, 442 Prioleau JE, 1054 Rougier P, 252 Shoemaker RH, 1383 Osborne MP, 617 Pritsos CA, 1161 Roush GC, 17 Shopland DR, 1748 Ouellet S, 1136 Probst M, 590 Rowinsky EK, 734, 817 Shrader MW, 123 Overgaard J, 918 Proby CM, 802 Roy DC, 1136 Shriner DA, 832, 1497 Overgaard M, 918 Pui C-H, 1840 Ruder AM, 1046 Shu X-O, 24 Pukkala E, 966 Rugge M, 762 Shults KE, 1483 P Pupa SM, 436, 1242 Rustum YM, 430 Sidransky D, 1580 Rutqvist L, 1497, 1543 Sievers EL, 1483 Q Ryan L, 668 Siewert JR, 1222 Padilla GM, 908 Rybak SM, 747 Sigvaldason H, 128 Palmgren J, 1560 Rytémaa T, 966 Siiteri P, 650, 756, 1127 Palumbo R, 1494 Qiao G, 1467 Sikes RA, 794 Panico S, 291 Quebbeman E, 668 S Silliman RA, 701 Pantel K, 1222 Silvestrini R, 1499 Parazzini F, 1003 R Simi B, 899 Parimoo D, 1079 Saarikoski ST, 1853 Simon R, 1645 Park J-G, 1317 Sabbioni G, 1046 Sjégren S, 173, 1500 Park TW, 355 Raber MN, 462 Saggiorato E, 442 Skoczylas JZ, 918 Parmar MKB, 1645 Raderer M, i593 Saggioro A, 762 Skubitz KM, 765 Parshad R, 754 Radinsky R, 1700 Sahmoud T, 890 Slichenmeyer WJ, 817 Parsons JT, 1407 Ragot T, 1857 Salazar H, 1810 Smith FO, 1483 Parzuchowski J, 55 Raich P, 661 Salmon I, 594 Smith J, 817 Pasteels J-L, 594 Raju RVS, 556 Salomaa E-R, 1560 Smith JM, 123 Pastorino U, 1241 Rak JW, 1285 Samet JM, 1031 Smith JW, II, 44 Patel J, 81 Ramanujam PS, 81 Sancar A, 1346 Smith KR, 872 Paterson A, 1529 Rautalahti M, 1560 Sanford KK, 754 Smith MA, 407, 1787 Patronek GJ, 1686 Ravdin P, 1456 Sanseverino P, 465, 1000 Snipes KP, 456 Paull KD, 259, 1161 Raygada M, 1821 Santi L, 583 Snow GB, 530 Pavirani A, 1857 Reaman GH, 24 Sartor O, 924 Snyder ML, 1399 Paz-Ares L, 1320 Recant WM, 1764 Sartorius S, 817 Soberman MS, 50 Pearson JW, 747 Redmond C, 1529 Saulnier P, 1857 Soda H, 1240 Peer CW, 123 Rees-McGee S, 81 Sausville EA, 956 Soldati T, 465, 1000 Peereboom D, 734 Regazzi MB, 1494 Schantz SP, 530 Solomayer EF, 1652 Pei H, 1489 Reisbacka H, 966 Schatz C, 1857 Sondak VK, 252, 927 Pendergrass TW, 24 Reitherman RW, 128 Scheithauer W, 1593 Soussi T, 1228 Perera FP, 496 Relling MV, 1840 Scher HI, 1623 Speizer FE, 365, 1375 Perez-Perez Gl, 465, 763 Restifo NP, 100 Schiller JT, 1467 Spence SE, 747 Perkins Cl, 456 Reynolds P, 1867 Schinkel AH, 994 Spicer DV, 128 Perloff M, 661 Rhyu MS, 240 Schluepen EM, 590 Spiegel D, 629 Perreault C, 1136 Richardson ES, 372 Schmitz PI, 1393 Spiegelman D, 1369 Perricaudet M, 1857 Richart RM, 355 Schnieders B, 1269 Spitz MR, 530 Perry HR, 754 Ries LAG, 1571 Schnitt SJ, 1054 Sporn MB, 123 Perry RR, 279 Riggs CW, 747 Schoenberg JB, 612 Spring SB, 1436 Persky V, 1127 Rilke F, 1002 Scholnick SB, 1676 Sredni B, 1276 Peters LJ, 1308 Rischin D, 1297 Schou G, 128 Srivastava S, 331 Peto R, 1791 Ritenbaugh C, 81 Schroeder G, 1039 St. Croix B, 1285 Petrelli NJ, 1665 Rivenson A, 899 Schwaab G, 1228 Stampfer MJ, 988, 1118, 1375 Phelps J, 81 Ro JY, 519 Schwab D, 1580 Stein CA, 391 Phillips KK, 1731 Roberson KM, 908 Schwaiger M, 1204 Stein U, 1383 Piatyszek M4, 116, 839 Robert-Guroff M, 372 Schwartz SM, 210 Steis RG, 44 Piccirillo JF, 1676 Roberts AB, 123 Sciajno R, 291 Stern TL, 372 Piedbois P, 252 Roberts DR, 1046 Seagren SL, 1210 Stevens MM, 1848 Pienta KJ, 55 Roberts R, 1659 Secreto G, 291 Stillman IE, 1054 Pietinen P, 1560 Robertson CN, 908 Segui J, 1078 Stjernberg N, 1302 Pike MC, 128, 650 Robidoux A, 1529 Seifter EJ, 126, 208 Stoler D, 1665 Pilotti S, 1002 Robison LL, 24 Semjonow A, 1594 Storm H, 128, 727 Pisani P, 291 Rocha RL, 601 Sepkovic DW, 617 Story JA, 81 Plewig G, 802 Roche B, 1228 Serini G, 442 Stoter G, 1393 Pollard M, 56 Roder JD, 1222 Seynaeve C, 1393 Stovali MA, 270 Ponzetto A, 465, 1000 Rodriguez-Bigas M, 1665 Shah KV, 1060, 1068 Strassman G, 1276 Popescu NC, 450 Rogatko A, 462 Sharnanin V, 802 Streicher RP, 1046 Porfirio B, 1865 Rémer W, 1204 Shani A, 1276 Stukel TA, 1848 Porrath SA, 128 Rommel B, 1234 Sharfman WH, 44 Sumizawa T, 1110 1876 AUTHOR INDEX Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 Sun C, i467 Travis LB, 51 Wan M, 510 Workman P, 259, 1161 Sun J, 607 Travis WD, 52 Wang P, 1152 Worland PJ, 956 Sun X-W, 355 Trent JM, 1731 Wang Q, 956 Wright TC, Jr, 355 Sunwoo JB, 1676 Tretli S, 128, 727 Wang Y, 1467 Wright WE, 456 Suzuki M, 467 Trichopoulos D, 883 Wanschura S, 1234 Wu AH, 650 Svingen PA, 734 Trimble EL, 812 Ward AJ, 377 Wynder EL, 183, 377, 1867 Swain SM, 1510 Tross S, 661 Ward EM, 1046 Wynn TT, 899 Swanson CA, 756, 1127 Trusolino L, 442 Ward JH, 872 Swanson GM, 377 Tu ZN, 519 Wargovich MJ, 67 xX Swanson MK, 340 Tucker MA, 1492 Warmerdam PG, 54 Swenson K, 842 Tulinius H, 128 Wasson JH, 166 Synold T, 1495 Tursz T, 1857 Watanabe M, 1240 Xu D, 1467 Sznol M, 44 Twiggs LB, 1127 Waters DJ, 1686 Xue L, 1586 Watson PH, 284 T U Weber W, 1204 Y Webster LK, 1297 Ungerleider RS, 812, 1645 Weed DL, 1698 Tabar L, 52 Urba WJ, 44 Weichselbaum RR, 1764 Yamada K, 1110 Tafur L, 1068 Urcelay B, 198 Weisburger JH, 836 Yamada Y, 1110 Tagliabue E, 1241 Ursin G, 128, 1332 Weiss JE, 1848 Yan M, 1467 Taioli E, 617 Weiss NS, 210, 764 Yang K, 1586 Takahashi K, 686 Vv Weissman BE, 1731 Yang N-S, 607 Takahashi Y, 1146 Welch DR, 1731 Yannelli JR, 100 TTTTTTaaaaaallklknabaeea osbdktkEaaa a,y MaM1Ks,G,5,h G6 i,1076 2 4822Y618 , 0 4161 10 VVVVvaaaaailnilte natninAitiosnis pen HnieB , r, ePA n1,,18 5514J5321,0 8 99 94 WWWWWeeeeelllrnlllsnssstb oe DHSrAABNg,,,, JJ111rE3,64, 978 690381 066 YYYYYYeeaooolernokl be iorndDGyo ,aHau F,m6gJ J0,ha, 1 16 15W7T185,G40 ,6 1 161,4 8893 9 Tangi I, 973 van den Brandt PA, 93, 768 West DW, 650 Young, JL, Jr, 456 Tangrea JA, 1560 van der Maas PJ, 54 Westra WH, 1580 Yu WL, 1000 Tannock IF, 206 van der Ploeg HM, 1478 Whang-Peng J, 1000 Yuan Y, 1317 Taplin SH, 643 van Leeuwen FE, 209, 1759 Whelan T, 1659 TTaarsoknien enR E,E, 11557610 vvaann TPeolplpienlg eGn, O9,3 994 WWhiibtauel tE , P2,1 01,2 2684 3 Z Tattersall MNH, 1331 Varricchio CG, 459 Wickerham DL, 1529 Taube S, 1456 Vasilev SA, 1361 Wieand HS, 1039 Zahurak M, 1580 Taubenberger J, 100 Vaughan TL, 542 Wigginton JM, 38 Zang EA, 183, 764, 899, 1867 Taylor PR, 1560 Velicescu M, 510 Wilbanks GD, 1127 Zatonski W, 727 Teass AW, 1046 Vena JE, 340 Wilczynski SP, 1361 Zequeira MR, 1676 Tejeda HA, 812 Vergara A, 1060 Wilkinson RH, 1659 Zhang L, 1399 Teppo L, 727, 1408, 1560 Verweij J, 1393 Willan A, 1659 Zhang Z, 530 Terz J, 1529 Vidal-Vanaclocha F, 198 Willett WC, 1375 Zhao Z, 899 Thalmann GN, 794 Vikram B, 1779 Williams JH, Jr, 1550 Zheng J. 510 Thomas DB, 542 Viladiu P, 1060 Wilson LMK, 270 Zhu B-P, 841, 1158 Thompson M, 301, 1237, 1592 Villamor J, 303 Wiltrout RH, 38 Ziegler A, 349 Thorban S, 1222 Virtamo J, 1560 Wing A, 1375 Ziegler RG, 612, 650 Thornquist MD, 1550 Vitale V, 583 Wingard DL, 1867 Ziegler S, 1204 Tichler T, 1276 Volkenandt M, 590 Winn RJ, 1456 Zimonjic DB, 450 Tobi H, 530 von Eschenbach AC, 794 Winter DL, 270 Zocchi M, 436, 1242 Toma S, 1494 von Minckwitz G, 1652 Wiseman RW, 552 Zéchbauer S, 1593 Tomita Y, 686 Volker K, 747 Wolff H, 802 Zon G, 419 Toner GC, 1297 Vriesendorp HM, 1405 Wolk A, 1472 Zuna RE, 980, 1779 Tonino P, 198 Wolmark N, 1529 Zupi G, 419 Tormey DC, 668, 1828 Ww Won Y-J, 1317 zur Hausen H, 802 Tortora G, 1770 Wood W, 661 Trachman J, 617 Wahlqvist ML, 378 Woods MN, 1369 Trail N, 1369 Walther W, 1383 Woollett AM, 1297 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 AUTHOR INDEX 1877 Antisense oligodeoxynucleotides, antitumor effects, 391 (editorial), 419 SUBJECT Antitumor effector cells, immunotherapies and gene encoding for, 1639 Apoptosis INDEX p53-mediated, 1449 paclitaxel (mice), 1308 Todaro and De Larco’s hypothesis of tumor growth, revised (cor- respondence), 1239 Aromatic amines, bladder cancer incidence and exposure in a chemi- cal plant, 1046 A AS101 immunoregulator, and T helper, 1276 Asbestos, glutathione S-transferase and N-acetyltransferase genotypes, Abortion, bias, and breast cancer, 1759 (editorial), 1698 and pulmonary disorders, 1853 N-Acetyltransferase, genotype and asbestos-associated pulmonary dis- Asian-Americans, breast cancer and height and weight, 650 orders, 1853 Aspirin, breast cancer risk, 941 (editorial), 988 Adenovirus-mediated gene transfer, lung cancer, 241 Astrocytic tumor, gastrin and cell proliferation, 594 Adhesion molecule expression, levamisole’s effect on colon tumor ATBC Study see Alpha-Tocopherol, Beta-Carotene Cancer Prevention cell line, 109 Study Adolescents, smoking by race, 1158 Atlas of Diagnostic Oncology, second edition (book review), 1076 African Americans Atlas of Surgical Oncology (book review), 127 breast cancer prevention (editorial), 1331 clinical trials, 812 prostate cancer, incidence trends, U.S., 1683 B women, diet change, and hormone levels, 1369 Age Basal cell carcinoma breast cancer care, 701 (editorial), 716 molecular epidemiology (editorial), 315 cancer susceptibility, 503 sunlight and genetic alteration, 349 AIDS, brain lymphoma and, 675 B-cells, non-Hodgkin’s lymphoma, translocation, 973 Alcohol consumption Bcl-2, urinary tract transitional cell cancer, prognosis and (correspon- infant leukemia risk, 24 dence), 686 lung cancer and, 1554 Behavior, BRCA| testing (commentary), 872 Alcoholism, head and neck cancer and, 542 Bias, abortion and breast cancer, 1759 (editorial), 1698 Alkaline phosphatase, ADEPT systems, 158 Bile acids, fecal, wheat bran fiber and calcium, adenomatous colon Alkylating agents polyps, 81 bone cancer following childhood cancers, 270 Biliary tract cancers, risk in diabetes mellitus, 1472 DNA adducts, 1347 repair and resistance, 1352 Biomarkers, head and neck squamous cell carcinoma, 518 secondary AML, 408 Bioregulators, (editorial), 479 (erratum), 1080 All-trans-retinoic acid (ATRA), aleukemic granulocytic sarcoma (cor- Blacks see African American respondence), 1494 Bladder cancer, aromatic amine exposure in a chemical plant, 1046 Alpha-fetoprotein, modernized version of Todaro and De Larco’s Bleeding, diethy|stilbestrol (correspondence), 765 hypothesis of tumor growth (correspondence), 1239 Body mass see Weight Amino acids, branched-chain, oral administration and anorexia and Body size, lung cancer and gender, 183 caloric intake, 550 Bone cancer, radiotherapy, alkylating agents, for childhood cancers, Aminobipheny]l, ladder cancer and, 1046 270 Aminopeptidase, ADEPT systems, 157 Bone marrow AML see Leukemia, acute myelogenous breast cancer, micrometastatic cells vs nodal status for prognosis, Androgens, (serum levels), menopause and subsequent breast cancer, 1652 290 esophageal cancer and disseminated tumor cells, 1222 Androstenedione, endometrial cancer risk, 1027 fibroblast growth factors, protection from radiation with, 1399 Angiogenesis, breast cancer (node negative) survival, 231 G-CSF prechemotherapy and, 1393 Aniline, bladder cancer and, 1046 Book reviews Anorexia, branched-chain amino acids, oral administration and caloric Atlas of Diagnostic Oncology, 2nd edition, 1076 intake, 550 Atlas of Surgical Oncology, 127 Anti-Cancer Treatment, Sixth international Congress on, report (cor- Breast Cancer: A Practical Guide to Diagnosis. Volume 1—Proce- respondence), 686 dures, 683 Antibody-directed enzyme prodrug therapy (ADEPT), 153 Breast Cancer: What Every Woman Should Know, 301 Antibody—enzyme conjugates, 153 Cancer of the Breast, 4th edition, 759 Antigens, cancer regression, genes encoded for, and immunotherapies, Cancer Prevention and Control, 126 1635 Cancer Wars: How Politics Shapes What We Know and Don’t Know Antimetabolites, topotecan interaction and human cancer cell lines, About Cancer, 208 734 Chemical Induction of Cancer: Modulation and Combination Ef- Antimicrotubule agents, topotecan interaction and human cancer cell fects—An Inventory of the Many Factors Which Influence Car- lines, 734 cinogenesis, 836 Antipyrine, impaired hepatic function, 817 Clinical Oncology, 126 1878 SUBJECT INDEX Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 Comprehensive Textbook of Genitourinary Oncology, 924 radiotherapy The Cure of Childhood Leukemia: Into the Age of Miracles, 375 early stage, older women, 716 Early Breast Cancer, 127 following lumpectomy and axillary dissection for node-negativity, Esophageal Surgery, 50 clinical trial, 1659 Finding a Lump in Your Breast: Where to Go . . . What to Do, 1237 reporting bias, and abortion, 1759 (editorial), 1698 Handbook of Cancer Chemotherapy, 4th edition, 555 risk factors, 365 Helping Your Mate Face Breast Cancer: Tips for Becoming an Ef- aspirin, 941 (editorial), 988 fective Support Partner, 1591 diet and, 340 Hematology: Basic Principles and Practice, 2nd Edition, 126 estimation methods, 1315 No Less a Woman: Femininity, Sexuality and Breast Cancer, 2nd family history, 365 (correspondence), 1003 edition, 459 screening trials interpreted (correspondence), 52 Oxford Textbook of Oncology, 616 surgery, early stage, older women, 716 Systemic Radiotherapy With Monoclonal Antibodies: Options and susceptibility, 754 Problems, 1405 tamoxifen (correspondence), 210 Thoracic Surgery, 50 early stage, 2 vs 5 years, 1543 Waking Up, Fighting Back, 1777 node-negative, estrogen receptor-positive tumors, 5 vs >5 years, Brain lymphoma, with or without AIDS, 675 1529 BRCAI telomerase activity (correspondence), 839 ovarian cancer, detected by protein truncation test, 552 second cancers, 832 (correspondence), 1496 testing, behavioral and psychosocial effects (commentary), 872 tumor marker-immunostaining intensity, 1054 BRCA2 (correspondence), 1408 wheat bran and psyllium diets (rats), 899 Breast Breast Cancer: A Practical Guide to Diagnosis. Volume 1—Proce- tumors and telomerase, 116 dures (book review), 683 estrogen receptor variants in normal human tissue, 284 Breast Cancer: What Every Woman Should Know (book review), 30! Breast cancer Burkitt’s lymphoma, EBV and (commentary), 1438 abortion and bias, 1759 (editorial), 1698 axillary lymph node involvement, PET using F-18 FDG, 1204 c-erbB-2 alteration (correspondence), 1002 C chemoprevention (rats), 123 DNA repair and, 754 cagA status, Helicobacter pylori and atrophic gastritis (correspon- elderly, care for the, 701 (editorial), 716 dence), 1000 estrogen-independent, c-myc and tamoxifen-induced apoptosis, 279 cagA, Helicobacter pylori and atrophic gastritis (correspondence), 465 fat (dietary) and, measurement error and results from analytic Calcium (dietary) epidemiology, 1738 colorectal cancer among women, 1375 fatty acids (dietary) during pregnancy (rats), 1821 colon cancer, 67 (editorial), 81 fiber and (editorial), 857 epithelial cell hyperproliferation in exocrine pancreas (mice), 1586 G-CSF prechemotherapy and bone marrow, 1393 Caloric intake, branched-chain amino acids, oral administration and height and weight in Asian-Americans, 650 anorexia, 550 hyaluronidase and drug resistance, 1285 Cancer and Leukemia Group B (CALGB) trial IL-10 and tumor growth (mice), 536 breast cancer outcome and psychological predictors, 661 incidence, survival, and mortality, 1571 lung cancer, non-small-cell, survival in stage III, 1210 insulin-like growth factor-binding protein-3 messenger RNA and Cancer of the Breast, 4th edition (book review), 759 prognosis, 601 Cancer Prevention and Control (book review), 126 log-incidence model, 359 Cancer Wars: How Politics Shapes What We Know and Don’t Know micrometastatic cells in bone marrow at primary surgery vs nodal About Cancer (book review), 208 status for prognosis, 1652 Carboxypeptidase A, ADEPT systems, 157 node-negative Carboxypeptidase G2 (CPG2), ADEPT systems, 156 angiogenesis and survival, 231 Carcinogenesis, mechanisms, 498 estrogen receptor-positive tumors, tamoxifen, 5 vs >5 years, 1529 Carcinogens, smoking-related and their metabolism, 23D preliminary results from the Cancer Research Campaign trial CARET see Beta-Carotene and Retinol Efficacy Trial evaluating tamoxifen duration in women aged 50 years or older a-Carotene, lung cancer and, 612 with, 1834 6-Carotene p53 ATBC Study, 1560 alteration (correspondence), 1002 CARET, 1550 immunostaining intensity and (editorial), 1015 colorectal cancer (correspondence), 377 prognosis, 141 (editorial), 173 (correspondence), 1499 lung cancer and, 612, 1513 (editorial), 1550, 1560 personality factors and, 1478 Carotenoids Pike model, 365 breast cancer risk, 340 postmenopausal ovarian cancer and serum micronutrients, 32 early stage, tamoxifen for 2 vs 5 years, 1543 Catalytic antibodies, ADEPT systems, 162 node-positive, postchemotherapy adjuvant tamoxifen therapy 6-Catenin, immunotherapies and gene encoding for, 1638 beyond 5 years in patients with, 1828 CDKN2 sex hormones (serum levels), 291! mutation, and ductal pancreatic adenocarcinoma, 680 prevention in African-American women (editorial), 1332 familial tumor syndrome and, 1489 psychological distress and disease course, 629 (editorial), 661 Cecum, irinotecan and (mice) (correspondence), 1240 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 SUBJECT INDEX 1879 Cell adhesion, myeloid levamisole’s effect on colon tumor cell line, minorities (correspondence), 377 109 phase II false positive, false negative (correspondence), 462 c-erbB-2, breast cancer and alteration (correspondence), 1002 prostate cancer, relapsed, 1623 Cervical cancer prostate-specific antigen (editorial), 779 control (editorial), 317 racial representation, 812 human papillomavirus c-myc HPV 18 and prognosis, 1361 oligodeoxynucleotides, antitumor effects, 391 (editorial), 419 male sexual behavior, Colombia, 1068 tamoxifen-induced apoptosis in estrogen-independent breast cancer male sexual behavior, Spain, 1060 cells, 279 type and squamous intraepithelial lesions, 355 Cognition, determinants of survival in older patients, 1031 intraepithelial neoplasia (CIN) (editorial), 317 Colombia, cervical cancer, male sexual behavior and human papillo- peritoneal cytology (editorial), 939, 980 (correspondence), 1779 mavirus DNA, 1060 prognosis (editorial), 1331 Colon cancer screening (editorial), 317 clinical trials, 1646, 1648 screening North Carolina Cherokee, and health education, 1670 diet, 67 (editorial), 81 Chemical exposure, bladder cancer and, 1046 levamisol and fluorouracil, ana inflammatory bowel disease (corre- Chemical Induction of Cancer: Modulation and Combination Ef- spondence), 303 fects—An Inventory of the Many Factors Which Influence Car- multidrug resistance, reversal by transduction of cytokine genes, 1383 cinogenesis (book review), 836 platelet-derived endothelial growth factor and angiogenesis, 1146 Chemoprevention, mammary carcinogenesis (rats), 123 Colon tumor (cell line), levamisole and, 109 Chemotherapy Colorectal adenoma head and neck squamous cell carcinoma, alternating with diet and (correspondence), 377 radiotherapy, vs radiotherapy alone, 582 smoking and, 1717 DNA adducts, 1346 Colorectal cancer Chemotherapy calcium and vitamin D among women, 1375 drug resistance and DNA repair, 1350 fluoropyrimidines and (6R,S) leucovorin (rats), 430 FUDR with HAI vs IVS, 252 fluorouracil administration (bolus vs infusion) with or without cispla- head and neck cancer (editorial), 855 tin, 668 head and neck squamous cell carcinoma, clinical trial (correspon- genetic screening, NCI workshop (commentary), 331 dence), 1407 hepatic arterial infusion for nonresectabie liver metastases (corre- non-small-cell lung cancer, unresectable stage III (editorial), 1175 spondence), 838 primary, head and neck cancer, advanced (editorial), 567 hereditary nonpolyposis radiosensitizing nucleosides, 1193 hMLH1I and 2 genes, Korea, 1317 synergy (editorial), 699 molecular mechanisms, 240 Cherokee, North Carolina, health education and cervical cancer liver metastases and hepatic arterial infusion, 252 screening, 1670 smoking and Childhood cancers trends, 1717 acute myeloid leukemia relapse, prediction by flow cytometry, 1483 Sweden, 1302 bone cancer following radiotherapy and alkylating agents, 270 sporadic, p53 tumor suppressor gene status and the degree of China, esophageal cancer and HPV 16, 1467 genomic instability, 1665 Chlamydia trachomatis, cervical cancer risk factors, Colombia, 1060 thymidine phosphorylase and prognosis, 1110 Chloroethyinitrosoureas (CENUs) Combined-action terms (editorial), 699 DNA adducts, 1347 Comprehensive Textbook of Genitourinary Oncology (book review), repair and resistance, 1352 924 Cholecystokinin (CCK), astrocytic tumor cell proliferation, 594 Counseling Chromosomes see also X Chromosome BRCA|I testing (commentary), 872 3(p14), Kaposi’s sarcoma, 450 prostatectomy, 139 6p21, breakpoints, pulmonary chondroid hamartomas, 1234 Cremophor, pharmacokinetics, with infusions of paclitaxel, 1297 allelic loss and outcome in squamous cell carcinoma of the supra- The Cure of Childhood Leukemia: Into the Age of Miracles, (book glottic larynx, 1676 Cigarette smoking see Smoking review), 375 Cisplatin CWR22 xenograft, prostate cancer gene therapy, 607 colorectal cancer, 668 Cyclin D1, drug sensitivity in human fibrosarcoma cell line, 1255 topotecan interaction and human cancer cell lines, 734 (editorial), 1269 Clinical Oncology (book review), 126 Cysteine, ovarian tumors (rats), 193 Clinical trials Cytarabine, drug sensitivity in human fibrosarcoma cell line, 1255 breast cancer, irradiation following lumpectomy and axillary dissec- (editorial), 1269 tion for node-negativity, 1659 Cytokines, see also Interleukin confirmatory randomized, 1606 (editorial), 1645 gene transduction into colon carcinoma cells to reverse multidrug false-positive results, 206 resistance, 1383 head and neck squamous cell carcinoma, radiotherapy and chemo- Cytosine deaminase, ADEPT systems, 162 therapy, 582 (correspondence), 1407 Cytotoxicity interpretation, 1647 synergy (editorial), 699 larynx preservation in pyriform sinus cancer, 890 drug sensitivity in human fibrosarcoma cell line, 1255 (editorial), lung cancer, non-small-cell, survival in stage III, 1210 1269 1880 SUBJECT INDEX Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 D Epidemiology, breast cancer and dietary fat, measurement error and results, 1738 Denmark Epithelial cell hyperproliferation, exocrine pancreas, induced by prostate cancer (correspondence), 128 Western-style diet (mice), 1586 testicular cancer incidence, 727 Epstein-Barr virus vaccines (commentary), 1436 Developmental sequence, prostate cancer, 1630 Errata Dexamethasone, hypersensitivity reactions and paclitaxel (correspon- “Bioregulators Come of Age in the Control of Tumor Growth and Metastasis,” by Nicolson [J Natl Cancer Inst 1996;88:479-80 dence), 463 Diabetes mellitus, liver and biliary tract cancer risk, 1472 (Issue 8)], 1080 Diagnosis “Human Lung Carcinogen-DNA Adduct Levels Mediated by determinants of surviva! in older patients, 1031 Genetic Polymorphisms In Vivo,” by Kato et al. [J Natl Cancer molecular, 1447 Inst 1995; 87:902-7 (Issue 12)], 1595 Diet “Reduction of Oncoprotein Transformation In Vitro by Albumin,” breast cancer risk, 340 Correspondence by Raju et al. [J Natl Cancer Inst 1996;88:556-7 change and hormone levels in African-American women, 1369 (Issue 8)], 769 : colorectal cancer, 377 (correspondence), 1375 Esophageal cancer ‘ pancreas, exocrine, and epithelial cell hyperproliferation (mice), bone marrow and disseminated tumor cells, 1222 ; 1586 HPV 16 and, 1421 (editorial), 1467 § prostate cancer (mice) (correspondence), 56 Esophageal Surgery (book review), 50 Diethylstilbestrol Estradiol, prostate cancer risk and, 1118 prostate cancer cells, 908 Estrogen diet change and, African-American women, 1369 uncontrolled bleeding in cancer (correspondence), 765 DNA endogenous, and body mass in menopause, 756 alkylating agents, topotecan interaction and human cancer cell lines, menopause and subsequent breast cancer, 290 734 metabolism, ethnicity and (correspondence), 617 damage receptor-negative cancers, tamoxifen (editorial), 225 apoptotic response pathways, p53 and, 1442 receptors, variants in normal human m><:imary tissue, 284 -inducible repair and resistance, 1353 replacement therapy (ERT), mammography and, 627 (editorial), 643 repair and leukemogenesis, 409 Ethnicity, see also Race, estrogen metabolism, and (correspondence), 617 recombination, leukemia cells, etoposide, cytotoxicity and site- specificity, 1840 Etoposide, leukemia cells, cytotoxicity and site-specific DNA recom- repair bination, 24G breast cancer and, 754 Europe, testicular cancer incidence, 727 enzymatic mechanisms and drug response, 1346 Ewing’s sarcoma, validation of cancer in deceased family members, 1492 sequencing, complementary vs immunohistochemistry, breast cancer prognosis and, 173 Docetaxel treatment, typhlitis and (correspondence), 1078 F Dogs, prostate cancer, age at diagnosis (correspondence), 1686 Doxorubicin False-positive results, clinical trials, 206 drug sensitivity in human fibrosarcoma cell line, 1255 (editorial), Familial tumor syndrome, pl6lNK4a tumor suppressor gene, 1489 1269 Family history MRP/GS-X pump (correspondence), 466 Drug resistance, breast cancer and hyaluronidase, 1285 breast cancer, 365 (correspondence), 1003 validation of cancer in deceased family members, 1492 Drug sensitivity, regulatory genes and, 1255 (editorial), 1269 Fat (dietary) DT-diaphorase, NCI cell lines, 259 breast cancer and, measurement error and results results from analytic epidemiology, 1738 colorectal cancer (correspondence), 377 E epithelial cell hyperproliferation in exocrine pancreas (mice), 1586 Fatty acids, dietary, during pregnancy, and breast cancer (rats), 1821 EO9, reductase enzyme expression in NCI cell lines (correspondence), Fiber (dietary) 259, 1161 breast cancer and, 340 (editorial), 857 Early Breast Cancer (book review), 127 colorectal cancer (correspondence), 377 E-cadherin, thyroid cancer, 442 diet and colon cancer, 67 (editorial), 81 Education mammary cancer (rats), 899 cervical cancer screening, Cherokee, North Carolina, 1670 Fibrosarcoma cell line, drug sensitivity and cyclin D1, 1255 cervical cancer risk factors, Colombia, 1060 (editorial), 1269 determinants of survival in older patients, 1031 Finding a Lump in Your Breast: Where to Go . . . What to Do, (book smoking and (correspondence), 840 review), 1237 Elderly, breast cancer care, 701 (editorial), 716 Finland Endometrial cancer lung cancer risk and radon exposure, 966 endogenous steroid hormones and, 1027 ovarian cancer and selenium (correspondence), 1408 peritoneal cytology (editorial), 939 (correspondence), 980, 1779 pulmonary disorders, asbestos and glutathione S-transferase and N- tamoxifen therapy and (correspondence), 210 acetyltransferase genotypes, 1853 Environmental factors, molecular epidemiology and, 496 testicular cancer incidence, 727 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 SUBJECT INDEX 1881 Flavonols, cancer risk and, 93 Glutathione S-transferase, genotype and asbestos-associated pul- Flow cytometry, pediatric acute myeloid leukemia relapse prediction, monary disorders, 1853 1483 Glycosidases, ADEPT systems, 158 Floxuridine (FUDR), HAI vs IVC, 252 gp100, immunotherapies and gene encoding for, 1636 Fludarabine, radiosensitization, 1198 Grading system (editorial), 1419 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose, axillary lymph node involve- Granulocyte colony-stimulating factor (G-CSF), prechemotherapy ment in breast cancer, 1204 and bone marrow, 1393 Fluoropyrimidines Granulocytic sarcoma, aleukemic, (correspondence), 1494 biochemical modulation (editorial), 393 Growth factor receptor, epidermal, protein kinase A and, for an- colorectal carcinoma (rats), 430 titumor activity, 1770 radiosensitization, 1193 Growth factors Fluorouracil -binding protein-3, insulin-like, messenger RNA, breast cancer prog- administration (bolus vs infusion) in colorectal cancer, 668 nosis and, 601 colon cancer, and inflammatory bowel disease (correspondence), 303 fibroblast, myeloprotective doses and tumor growth and radiosen- Folic acid sitivity (mice), 1399 breast cancer risk, 340 platelet-derived endothelial, colon cancer angiogenesis, 1146 lometrexol toxicity and (correspondence), 1495 Gynecologic cancer, peritoneal cytology, 939 (editorial), 980 (corre- Fruits, breast cancer risk, 340 spondence), 1779 Fusion proteins, ADEPT systems, 162 H G Handbook of Cancer Chemotherapy, 4th edition (book review), 555 HBL-100 cell lines, Mason—Pfizer monkey virus, 372 G2, UCN-01 and function, 956 Head and neck cancer Gastrin, astrocytic tumor cell proliferation, 594 advanced, primary chemotherapy (editorial), 567 Gastritis, atrophic alcoholism and, 542 Helicobacter pylori and (correspondence), 762 Bcl-2 overexpression and smoking history in, 1864 Helicobacter pylori and cagA (correspondence), 465 (correspon- induction chemotherapy (editorial), 855 dence), 1000 radiotherapy and neuropathy following paclitaxel (correspondence), Gastrointestinal cancer, tamoxifen and (correspondence), 1496 1000 Gemcitabine, radiosensitization, 1198 squamous cell carcinoma Gender genetic susceptibility, 530 cancer susceptibility, 504 p53 mutation and treatment failure, 1580 lung cancer risk (correspondence), 764 p53 serum antibodies, 1228 Gene therapy p53 to predict recurrence and second primary tumors, 518 p53 and, 1449 radiotherapy alternating with chemotherapy compared with prostate cancer, and CWR22 xenograft model for, 607 radiotherapy alone, 582 (correspondence), 1407 Genes see also particular gene supraglottic larynx, chromosome 8 allelic loss and outcome, 1676 cancer susceptibility, 500 vinorelbine and acute tumor pain (correspondence), 1593 colorectal cancer, hMLH1 and 2 in hereditary nonpolyposis, Korea, Health education, cervical cancer screening, North Carolina Cherokee, 1317 1670 colorectal cancer, smoking and, 1717 Height, weight and breast cancer in Asian-Americans, 650 colorectal cancer screening, NCI workshop (commentary), 331 Helicobacter pylori, atrophic gastritis and (correspondence), 762 colorectal carcinoma, heriditary nonpolyposis, 240 cagA status (correspondence), 465 (correspondence), 1000 cytokine, transduction into colon carcinoma cells to reverse multi- Helping Your Mate Face Breast Cancer: Tips for Becoming an Ef- drug resistance, 1383 fective Support Partner (book review), 1591 encoding cancer regression antigens, immunotherapies and, 1635 Hemangiopericytoma, interferon & (correspondence), 764 mdrla, Pgp deficiency and vinblastine pharmacokinetics (mice), 994 Hematology: Basic Principles and Practice, 2nd editon, (book metastasis-suppressors, 1731 (editorial), 1700 review), 126 “<r tumor suppressor, familial tumor syndrome and, 1489 Hepatic artery infusion pulmonary chondroid hamartomas, HMG-I(Y) and chromosome clinical and economic trade-offs, 223 (editorial), 252 6p21 breakpoints, 1234 nonresectable liver metastases from colorectal cancer (correspon- regulatory and drug sensitivity, 1255 (editorial), 1269 dence), 838 repair, expression in resistant cell lines, 1354 Hepatitis C virus, hepatocellular carcinoma among Japanese, 742 skin cancer, basal cell carcinoma and sunlight, 349 Hispanics, clinical trials, 812 transfer, adenoviral-mediated, lung cancer, 1857 Histocompatibility complex, major, levamisole’s effect on colon Genomic instability tumor cell line, 109 cancer and (editorial), 1608 History, validation of cancer in deceased family members, 1492 p53 tumor suppressor gene status and, sporadic colorectal cancers, HNPCC see Colorectal carcinoma, heriditary nonpolyposis 1665 Hodgkin’s disease Genotoxic lesions, repair, 1347 EBV and (commentary), 1439 Germany, testicular cancer incidence, 727 lung cancer (correspondence), 51 ¥-Glutamyl transpeptidase, glutathione and, ovarian tumors (rats), treatment, smoking, and lung cancer risk (correspondence), 209 193 Hormones 1882 SUBJECT INDEX Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996

ebook img

Journal of the National Cancer Institute 1996: Vol 88 Index PDF

23 Pages·1996·6.6 MB·English
by  
#periodicals #sim_microfilm #pub_journal-of-the-national-cancer-institute
Save to my drive
Quick download
Download
Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Journal of the National Cancer Institute 1996: Vol 88 Index

Banerjee D, 1269 Braakhuis BJ, 530 Chodak GW, 139 Barista I, 51, 838 Bradlow H, 617 Choe KJ, 1317 AUTHOR Barnett JB, 1369 Brandt B, 1594 Choi G, 519 Barnhart S, 1550 Brants HAM, 93 Chou CM, 1000 Barnhill RL, 17 Brash DE, 349 Chow W-H, 1472 INDEX Baron JA, 1848 Brassure JR, 340 Chrismon JH, 1158 Barrett MJ, 1560 Brawley OW, 812 Chu KC, 1571 Barrett RJ, 1127 Breant C, 1315 Chung LW, 794 Barry MJ, 166 Brennan JA, 1580 Chung W-K, 1308 Bartnitzke S, 1234 Brinton LA, 1127 Ciardiello F, 1770 Bartsch D, 680 Brodkin CA, 1550 Cirillo PM, 1867 Basik M, 1665 Brotchi J, 594 Citro G, 419 A Bast RC, 1456 Brown CC, 123 Clark L, 81 Bastert G, 1652 Brown CJ, 480 Clark RM, 1659 Baty BJ, 872 Brown KK, 1046 Clarke R, 1821 Abbruzzese JL, 462 Baty JD, 1676 Brownlee HA, 552 Cleary KR, 1146 Abbruzzese MC, 462 Bazzoli F, 465 Broxterman HJ, 466 Clerici E, 461 Abrams J, 759 Beaty TL, 536 Brubaker A, 817 Clerici M, 461 Adami H, 727, 883, 1216, Beauchamp AE, 44 Brunda MJ, 38 Cloos J, 530 1302, 1472, 1864 Beecher G, 1513 Bryant J, 1529 Cochran CJ, 552 Adér HJ, 1478 Beemsterboer PMM, 54 Bryant JL, 450 Cofer KF, 510 Aickin M, 81 Begg CB, 17 Bucana CD, 1146 Cohen LA, 899 Aikou T, 1110 Behrens A, 980 Buckley JD, 1483 Cohen RD, 1867 Akiba S, 1110 Beijnen JH, 994 Buckwalter CA, 734 Cohn BA, 1867 Akiyama S, 1110 Bellapravalu S, 81 Buer J, 590 Colavito EA, 612 Akova M, 51 Bellefleur J, 55 Buller MK, 81 Colditz GA, 359, 365, 988, Akre O, 727, 883 Benasso M, 583 Bullerdiek J, 1234 1375 Albanes D, 1560 Benito J, 1320 Burger RA, 1361 Cole BF, 223, 1039, 1686 Albeck M, 1276 Bennett WP, 52 Burk RD, 781 Collette L, 890 Alberg AJ, 32, 1408 Benson A, III, 668 Burke HB, 1864 Colnaghi MI, 1002 Alberts DS, 81 Bentzen SM, 918 Burt ME, 193 Colomer R, !320 Albertsen PC, 166, 1177 Berchuck A, 552 Burton HS, 270 Comstock GW, 32 Alexander FE, 54 Berg CD, 759 Buyse M, 252 Conlon KC, 44 Alfthan G, 1408 Bergh J, 173, 1499, 1500 Buzaid AC, 569 Conversano L, 550 Allen-Mersh T, 252 Bergstrém R, 727, 1216, 1302, Cook JM, 908 Alvarez A, 198 1864 Cc Cook J, 1399 Alvarez-Sala R, 303 Berman ML, 1127, 1361 Cook LS, 210 Alvord WG, 44 Berne C, 1472 Cortina R, 279 Anand A, 838 Bernstein ID, 1483 Calabretta B, 419 Corvo R, 583 Anand A, 838 Berrino F, 291 Callery MP, 680 Costa SD, 1652 Anand N, 838 Berry DA, 1606 Camalier R, 259, 1161 Costantino J, 1529 Anderson GR, 1665 Bertino JR, 1269 Camby I, 594 Coté TR, 675 Anderson M, 193 Berwick M, 17 Cangiano C, 550 Courtney M, 1857 Anderson T, 668 Bettinger L, 81 Cao S, 430 Creekmore SP, 44 Andremont A, 1857 Bianco AR, 1770 Cardenal F, 1078 Cremona O, 442 Angeli A, 442 Bianco C, 1770 Carillo B, 303 Croyle RT, 872 Anton-Culver H, 1361 Bianco R, 1770 Carlson R, 252 Cullen MR, 1550 Anzano MA, 123 Biela BH, 510 Casalini P, 1002 Culp J, 607 Aprelikova O, 1489 Bilim V, 686 Cascinelli N, 1002 Curti BD, 44 Arcuri T, 1494 Bishop JF, 1297 Case LD, 1670 Curtis RE, 52, 832, 1497 Ardelt W, 747 Black WC, 627 Casillas M, 303 Ariniello PD, 1136 Blaser MJ, 465, 763 Cassaro M, 762 D Aristizabal N, 1068 Bleiker EMA, 1478 Castellsagué X, 1060, 1068 Aromaa A, 1408 Blengio F, 583 Castrén O, 966 Ascunce N, 1060 Bleyer WA, 375, 377 Catane R, 1276 D’ Agnano I, 419 Askin FL, 1560 Blinson K, 1670 Celik I, 51, 838 Daigneault-Creech CA, 1483 Assmann G, 1594 Boehm DK, 463 Cella DF, 661 Daling JR, 210, 1421 Asumendi A, 198 Boente MP, 1810 Cennerazzo WJ, 1686 Dallmann I, 590 Atkins CD, 303, 1496 Boer R, 54 Chaney SG, 1346 Daly MB, 1810 Atwood J, 81 Boice JD, Jr, 52, 832, 1497 Chang A, 252 Damiano V, 1770 Atzpodien J, 590 Boivin, J-F, 209 Chang S-M, 794 Danguy A, 594 Auvinen A, 966 Bolelli G, 291 Chao Y, 1000 Datia RS, 556 Avril N, 1204 Bonelli L, 583 Chatenoud L, 1003 Davis S, 542 Boniver J, 824 Chen C-L, 1840 Davis S, 1670 B Bontenbal M, 1393 Chen H-H, 52 DeBord DG, 1046 Borst P, 994 Chen LT, 1000 de Castro J, 303 Bosch FX, 1060, 1068 Chen TL, 817 DeCillis A, 1529 Bacchetti S, 1152 Bosq J, 1228 Chen YM, 1000 Decher L, 842 Back TC, 38 Bostwick DG, 1686 Cheng L, 607 DeCosse JJ, 1686 Balch CM, 569 Botkin JR, 872 Cheng PC, 510 Defresne MP, 824 Baldeyrou P, 1857 Bourhis J, 1228 Cherniack MG, 1550 De Giovanni C, 926 Bale AE, 349 Bowling K, 817 Chevalier D, 890 De Giuli F, 465 Ballard-Barbash R, 716 Bowman DM, 1529 Chiesa G, 1242 Dr Giuli M, 1000 Balmes J, 1550 Boyd J, 1408 Cho E, 1821 de Koning HJ, 52, 54 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 AUTHOR INDEX 1873 Delvenne P, 824 Figueroa JA, 601 Gonzalez LC, 1060 Hendriks JHCL, 1478 Deleyiannis FW, 542 Fine JA, 17 Goodfellow PJ, 680 Hennekens CH, 1118 Deman J, 824 Fine RL, 908 Goodman GE, 1550 Henson DE, 1015 de Placido S, 1770 Firat D, 838 Goodman SN, 1580 Herndon JE, II, 661, 1210 De Rossi M, 442 Fishel R, 1608 Goodwin JS, 1031 Hertog MGL, 93 de Sanjosé S, 1060 Fisher B, 1529 Goos M, 802 Hertzmark E, 1369 Desch CE, 1456 Fisher ER, 1529 Gorbach SL, 1369 Herz M, 1204 Deschénes L, 1529 Fisher MC, 109 Gorlick R, 1269 Hess KR, 462 Devesa SS, 298 Fitzsimmons SA, 259, 1161 Gosewehr JA, 510 Heston WDW 57 de Villiers EM, 802 Fletcher SW, 627 Graeff H, 1204 Heyne K, 519 de Wit R, 1393 Flick BJ, 872 Graham CH, 1285 Hicks DJ, 1731 Diel IJ, 1652 Fogler WE, 747 Graham S, 340 Hidalgo M, 1320 Dignam J, 1529 Folkman J, 10°1 Grauman D, 298 High JL, 812 Dignan M, 1670 Fontanini G, 1770 Gray R, 1828 Hilakivi-Clarke L, 1821 Dillman RO, 1210 Forastiere AA, 817, 855, 1580 Greco WR, 699 Hilsenbeck SG, 601 Di Mario F, 762 Ford L, 812 Green MR, 1210 Hirohata T, 742 Dimitrov NV, 1529 Forrest AP, 54 Green SB, 812 Hirvonen A, 1853 Dinarello CA, 198 Fox KR, 1076 Greenberg ER, 1848 Hittelman WN, 519 Ding I, 1399 Franceschi S, 1003 Greenwald P, 1560 Hiyama E, | 16, 839 Donehower RC, 734, 817 Franco JL, 38 Greimers R, 824 Hiyama K, 116, 839 Dorgan JF, 1127 Frank C, 430 Grever M, 259, 1161 Hochhauser D, 1269 Doroshow JH, 393, 1495 Fraumeni JF, Jr, 298, 612, 650, Grochow LB, 734, 817 Hochwald SN, 193 Dose J, 1204 832, 1472, 1497 Groshen S, 1495 Hodge T, 1240 Driver CL, 123 Freedman LS, 1560 Gross EG, 349 Hoffman SC, 32 Dubeau L, 510 Freudenheim JL, 340 Grosse J, 590 Hogan DJ, 56 Dubois I, 1228 Friedman MA, 812 Gruber J, 1436 Hogan WM, 1810 Duensing S, 590 Fritsche H, Jr, 1456 Guerrero E, 1060 Holland JC, 661 Duffy SW, 52 Fukuda M, 1240 Guffroy M, 1240 Holland JF, 661 Fulton AM, 536 Giillii I, 51 Holle R, 1652 E Funk A, 1222 Gupta J, 1152 Holmberg L, 173, 1216, 1500, Fuscoe JC, 1840 1864 Futreal PA, 552 H Holmlund JT, 44 Eastman A, 956 Heng W, 519, 567 Eaton WL, Jr, 1210 G Hoover RN, 650, 756, 1127 Edwards BK, 1560, 1571 Haapakoski J, 1560 Horn-Ross PL, 650 Egan KM, 988 Hahm H, 555 Hdrte LG, i28 Eisenberger MA, 779 Gailani MR, 349 Hakama M, 966, 1408 Hoskins WJ, 1790 Ekbom A, 727, 883, 1302, Gallie BL, 1152 Hakulinen T, 128 Houghton J, 1834 1472 Gallo O, 1865 Hakulinen T, 727, 1408 Hsieh C-C, 883 El-Mofty SK, 1676 Gallo RC, 450 Haldorsen T, 128 Hsing AW, 1093 Elledge RM, 141 Galloway DA, 1421 Haller DG, 668 Hsu TC, 530 Ellis LM, 1146 Gann PH, 1118 Hamilton TC, 1810 Huang K, 1399 Elwood JM, 3 Ganser A, 590 Hamm H, 802 Hubbert NL, 1467 Engeland A, 128 Ganz PA, 1315 Hammar S, 1550 Huber ML, 55 Engholm G, 1302 Garbers S, 617 Han C, 1467 Humblet C, 824 Ercikan-Abali E, 1269 Garte SJ, 617 Han H-J, 1317 Hunt WC, 1031 Eriksen MP, 841 Gause BL, 44 Han L-P, 1152 Hunter DJ, 1375 Erozan Y, 1560 Gautier E, 1857 Handelman GJ, 1513 Hunter NR, 13%8 Eschwege F, 1228 Gazdar AF, 116, 839 Hankey BF, 52, 832, 1497, Husgafvel-Pursiainen K, 1853 Escobedo LG, 841, 1158 Geiser T, 419 1571 Huttunen JK, 1560 Esper PS, 55 Gelber RD, 1039, 1686 Hansen RM, 668 Ettinger D, 817 Gelmann EP, 224 Hardy CR, 675 Evans AC, 552 Gerber M, 857 Harlan LC, 716 Evans J, 1529 Ghaffari AM, 1060, 1068 Harris CC, 315, 1442 Ghilchik M, 839 Harris EL, 754 Ignacio V, §!/ F Gibson J", 1748 Harrison LE, 193 Ikematsu H, ‘4. Gili M, 1060 Hartge P, 298, 612, 675 Ikuno N, 1240 Giordano D, 1494 Hartman AM, 1560, 1748 Imai T, 686 Faessel H, 699 Giovanella BC, 372 Hascall G, 1436 Inganiis M, 173, 1500 Falkson HC, 1828 Giovannucci EL, 988, 1375, Haughey BH, 1676 Ishikawa T, 466 Fan J, 1269 1717 Haustein U, 802 Izarzugaza I, 1060 Farinati F, 762 Giovino GA, 841 Hawkins MM, 270 Fan S, 956 Glass AG, 1550 Hayes DF, 1456 J Farrar WB, 1529 Glickman LT, 1686 Hayman JA, 1866 Faulkner DL, 1158 Glisson BS, 567 Hayran M, 51 Fears TR, 298 Godorov G, 510 Heijn M, 466 Jackson JG, 601 Feig SA, 683 Godwin AK, 1810 Heimann R, 1754 Jackson MJ, 536 Feldman MI, 1529 Goepfert H, 519 Heinonen OP, 1560 Jacobs TW, 1054 Felix JC, 510 Goldbohm RA, 93, 768 Hejna M, 1593 Jinicke F, 1204 Fenton RG, 44 Goldgar DE, 872 Helgesen F, 1216, 1864 Janik JE, 44 Ferguson D, 1764 Goldhirsch A, 1039, 1686 Hellman S, 1764 Jeffers S, 1079 Ferrarini M, 436, 1242 Goldstein AM, 1492 Heltai S, 436, 1242 Jeffers S, 1495 Feuer EJ, 1683 Gollahon L, 116, 839 Helzlsouer KJ, 32, 754, 1408 Jenkins NH, 840 Fidler IJ, 1700 Gémez L, 303 Henderson BE, 1332 Jessup JM, 1456 1874. AUTHOR INDEX Journal of the National Cancer Institute, Vol. 86, No. 24, December 18, 1996 Johansson J-E, 1216, 1864 Krzywda B, 668 Liu TW, 1000 Micheli A, 291 Johnson A, 661 Ku J-L, 1317 Liu W, 1146 Michielutte R, 1670 Johnson DH, 1175, 1866 Kuipers EJ, 465, 763 LiVolsi VA, 939 Miele ME, 1731 Johnson ES, 51 Kundu N, 536 Llort G, 1078 Mikulski SM, 747 Johnson K, 1495 Kung H-F, 747 Locker GY, 1456 Milas L, 1308 Johnston DA, 794 Kunter U, 590 Logsdon DL, 123 Miller BA, 1571 Jolitz G, 842 Kuo M, 467 Loken MR, 1483 Miller LL, 44 Jung EG, 802 Kuroi K, 116, 839 Lollini P-L, 926 Millward M3, 1297 Junker R, 1594 Kurosaki T, 1361 Longcope C, 1118, 1369 Milross CG, 1308 Longo DL, 44, 747 Miyadera K, 1110 K L Lorberboum-Galski H, 973 Moghimi SM, 766 Lowy DR, 1467 Mohner M, 727 Kadish AS, 781 Laderoute MP, 210, 1239 Lozupone F, 419 Mokbel K, 839 Kahlenberg MS, 1665 Lake AJ, 650 Lubejko B, 817 Monier R, 1857 Kalechman Y, 1276 Lambert JM, 1136 Lubin R, 1228 Monk BJ, 1361 Kang K, 1317 Lampkin B, 24 Luboinski B, 890, 1228 Montes A, 1078 Kang Y, 279 Lamy D, 1857 Lunardi-Iskandar Y, 450 Moore DE, 210 Kapitain S, 1285 Lancaster JM, 552 Luo P, 510 Morgando A, 1000 Kaplan GA, 1867 Landuzzi L, 926 Luostarinen T, 128 Morin GB, 1095 Karagas MR, 1848 Lane PR, 56 Lurain JR, 1127 Morris CR, 456 Karp JE, 407, 1787 Lange BJ, 1483 Lu-Yao GL, 166 Morris JS, 32 Kashiwagi S, 742 Lankelma J, 466 Lynch HT, 1810 Mortel R, 1127 Katagiri A, 686 Larson EB, 643 Lynn WR, 1748 Morton CG, 1297 Kataoka T, 116, 839 Laub PB, 1810 Mueller MD, 1748 Kaufman B, 1276 Laughlin R, 340 M Muggia FM, 1079, 1495 Kaufmann M, 1652 Lavasseur L, 699 Muise-Helmericks R, 1269 Kaufmann SH, 734 La Vecchia C, 1003 MaJ, 1118 Mukhtar H, 768 Kaul S, 1652 Lavergne D, 802 Maatela J, 1408 Mulieri M, 550 Kawakami Y, 100 Laviano A, 550 MacLennan R, 377, 378 Mullen LT, 123 Kawasaki T, 686 Lawrence TS, 1193 Macdonald JS, 1456 Mulloy WP, 686 Kazmierczak B, 1234 Laya MB, 643 Macrae F, 378 Mufioz N, 1060, 1068 Kelly WK, 1623 Le Cesne A, 1857 Mahmoud H, 1840 Murata F, 1110 Kemeny M, 252 Le Chevalier T, 1857 Mahoney LJ, 1659 Murphy LC, 284 Kemeny N, 252, 1456 Le Houillier C, 1136 Mikelainer I, 966 Murray JC, 766 Keogh JP, 1550 Lee AV, 601 Maksymiuk AW, 463 Muti P, 291 Kerbel RS, 1285 Lee DJ, 1580 Malila N, 1560 Kessler LG, 716, 1571, 1748 Lee JJ, 519 Manns A, 675 N Kiang DT, 661 Lee JS, 519 Marandas P, 1228 Kim C-Y, 13!7 Lee J-H, 1731 Marchisio PC, 442 Nagler A, 973 Kim C-S, 908 Lee KH, 1317 Margarino G, 583 Naik H, 55 Kim J-P, 1317 Lee M, 842 Margolese RG, 1529 Nakamura Y, 1317 Kim K-Y, 1317 Lefebvre J-L, 890 Marincola FM, 100 Nanni P, 926 Kim S, 1317 Leffell DJ, 349 Marsden HB, 270 Nash JE, 872 Kim TM, 510 Leichman L, 1495 Marshall JR, 340 Nathrath W, 1204 Kimball ES, 109 Leigh IM, 802 Martinez J, 594 Navarro C, 1060 Kirchner H, 590 Lenzi R, 462 Martinez M, 1375, 1717 Nayfield SG, 716 Kirkpatrick A, 890 Leonetti C, 419 Mason KA, 1308 Negri E, 1003 Kirn DH, 764 Lerman C, 872 Mason TJ, 612 Nekarda H, 1222 Kiss R, 594 Leung D, 1586 Mattson K, 1853 Nelson WG, 779 Kitadai Y, 1146 Levasseur L, 669 Mayne ST, 1513 Nemoto T, 340 Kiviat NB, 317 Leventon-Kriss S, 450 Mazumdar M, 1623 Neumann C, 802 Klokman WJ, 209 Levin B, 67 McAdams MJ, 612 Newman E, 1495 Knekt P, 1408 Levine M, 1659 McCaffrey RP, 407 Newmark H, 1586 Knutsson A, 1302 Levy E, 252 McCulloch P, 1659 Newton DL, 747 Koch WM, 1580 Lewis AD, 259, 1161 McDonald JA, 1848 Nicoletti G, 926 Kohn KW, 1255 Leygue ER, 284 McGinn CJ, 1193 Nicolson GL, 479 Kohno S, 1240 Li L, 1467 McGuigan KA, 1315 Nomura AM, 650 Kolonel LN, 650 Li W-W, 1269 McKnight B, 210 Nooijen WJ, 994 Komschilies KL, 38 Li Y, 1467 McLaughlin JK, 1472 Norberg T, 173, 1500 Konen J, 1670 Lichter AS, 1866 McQuellon RP, 1670 Nordgren H, 173, 1500 Kopecky KJ, 927 Lickley HL, 1529 Meguid MM, 550 Norkus EP, 32 Kopp WC, 44 Liippo K, 1560 Mehl S, 617 Norton JA, 680 Kornblith AB, 661 Linahan BM, 1297 Melton RG, 153 Norton L, 661, 1456 Kornek G, 1593 Lindgren A, 173, 1500 Ménard S, 436, 1002, 1242 Novakovic B, 1492 Kornfehl H, 1593 Linet MS, 1472 Mendelsohn J, 1770 Numico G, 583 Korzun A, 661 Linnainmaa K, 1853 Mendenhall WM, 1407 Nyrén O, 1302, 1472 Koscielny S, 1228 Lipa M, 1659 Mennel RG, 1456 Nystrém L, 1302 Koskinen K, 1853 Lipkin M, 1586 Merlano M, 583, 1407 Koutsky LA, 317 Lippman ME, 1821 Merrill RM, 1683 O Kramer A, 764 Lippman SM, 519 Merritt RK, 1158 Kramer BS, 1698 Lishner M, 973 Mesia R, 1078 Krogh V, 291 Litwin S, 462 Meuwissen SG, 465, 763 O’Brien ET, 908 Krook JE, 1039, 1686 Liu JM, 1000 Meyskens FL, Jr, 927, 1550 O’Connell M, 252 Kruit WH, 1393 Liu Q, 1840 Michaels FH, 372 O’Connor PM, 956 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 AUTHOR INDEX. 1875 O'Reilly S, 616, 817 Potischman NA, 756, 1127 Rookus MA, 1759 Sharma RK, 556 Ogden GR, 1864 Potok MHN, 270 Rose BR, 1331 Sharp P, 1670 Oh J-H, 1317 Potosky AL, 166, 716, 1683 Rose DM, 193 Shay JW, 116, 839 Oh N-G, 1317 Powers C, 1764 Rosenberg L, 941 Shearer GM, 461 Oka M, 1240 Powers GC, 44 Rosenberg SA, 100, 1635 Sheehan C, 1285 Okunieff P, 1399 Prados C, 303 Rosenblum N, 1810 Sherwood RF, 153 Olshan AF, 1489 Prentice RL, 1419, 1738 Rosner BA, 359, 365, 988 Shevlin DS, 680 Omenn GS, 1550 Pretlow TG, 607 Ross JA, 24 Shewach DS, 1193 Onojafe I, 1821 Preziosa I, 550 Rossi SC, 331 Shibata H, 1529 Opolon P, 1857 Price FM, 754 Rossi-Fanelli F, 550 Shin DM, 519 Oppenheim JJ, 44 Priebe W, 467 Rosso R, 583 Shin HJC, 519 Orlandi F, 442 Prioleau JE, 1054 Rougier P, 252 Shoemaker RH, 1383 Osborne MP, 617 Pritsos CA, 1161 Roush GC, 17 Shopland DR, 1748 Ouellet S, 1136 Probst M, 590 Rowinsky EK, 734, 817 Shrader MW, 123 Overgaard J, 918 Proby CM, 802 Roy DC, 1136 Shriner DA, 832, 1497 Overgaard M, 918 Pui C-H, 1840 Ruder AM, 1046 Shu X-O, 24 Pukkala E, 966 Rugge M, 762 Shults KE, 1483 P Pupa SM, 436, 1242 Rustum YM, 430 Sidransky D, 1580 Rutqvist L, 1497, 1543 Sievers EL, 1483 Q Ryan L, 668 Siewert JR, 1222 Padilla GM, 908 Rybak SM, 747 Sigvaldason H, 128 Palmgren J, 1560 Rytémaa T, 966 Siiteri P, 650, 756, 1127 Palumbo R, 1494 Qiao G, 1467 Sikes RA, 794 Panico S, 291 Quebbeman E, 668 S Silliman RA, 701 Pantel K, 1222 Silvestrini R, 1499 Parazzini F, 1003 R Simi B, 899 Parimoo D, 1079 Saarikoski ST, 1853 Simon R, 1645 Park J-G, 1317 Sabbioni G, 1046 Sjégren S, 173, 1500 Park TW, 355 Raber MN, 462 Saggiorato E, 442 Skoczylas JZ, 918 Parmar MKB, 1645 Raderer M, i593 Saggioro A, 762 Skubitz KM, 765 Parshad R, 754 Radinsky R, 1700 Sahmoud T, 890 Slichenmeyer WJ, 817 Parsons JT, 1407 Ragot T, 1857 Salazar H, 1810 Smith FO, 1483 Parzuchowski J, 55 Raich P, 661 Salmon I, 594 Smith J, 817 Pasteels J-L, 594 Raju RVS, 556 Salomaa E-R, 1560 Smith JM, 123 Pastorino U, 1241 Rak JW, 1285 Samet JM, 1031 Smith JW, II, 44 Patel J, 81 Ramanujam PS, 81 Sancar A, 1346 Smith KR, 872 Paterson A, 1529 Rautalahti M, 1560 Sanford KK, 754 Smith MA, 407, 1787 Patronek GJ, 1686 Ravdin P, 1456 Sanseverino P, 465, 1000 Snipes KP, 456 Paull KD, 259, 1161 Raygada M, 1821 Santi L, 583 Snow GB, 530 Pavirani A, 1857 Reaman GH, 24 Sartor O, 924 Snyder ML, 1399 Paz-Ares L, 1320 Recant WM, 1764 Sartorius S, 817 Soberman MS, 50 Pearson JW, 747 Redmond C, 1529 Saulnier P, 1857 Soda H, 1240 Peer CW, 123 Rees-McGee S, 81 Sausville EA, 956 Soldati T, 465, 1000 Peereboom D, 734 Regazzi MB, 1494 Schantz SP, 530 Solomayer EF, 1652 Pei H, 1489 Reisbacka H, 966 Schatz C, 1857 Sondak VK, 252, 927 Pendergrass TW, 24 Reitherman RW, 128 Scheithauer W, 1593 Soussi T, 1228 Perera FP, 496 Relling MV, 1840 Scher HI, 1623 Speizer FE, 365, 1375 Perez-Perez Gl, 465, 763 Restifo NP, 100 Schiller JT, 1467 Spence SE, 747 Perkins Cl, 456 Reynolds P, 1867 Schinkel AH, 994 Spicer DV, 128 Perloff M, 661 Rhyu MS, 240 Schluepen EM, 590 Spiegel D, 629 Perreault C, 1136 Richardson ES, 372 Schmitz PI, 1393 Spiegelman D, 1369 Perricaudet M, 1857 Richart RM, 355 Schnieders B, 1269 Spitz MR, 530 Perry HR, 754 Ries LAG, 1571 Schnitt SJ, 1054 Sporn MB, 123 Perry RR, 279 Riggs CW, 747 Schoenberg JB, 612 Spring SB, 1436 Persky V, 1127 Rilke F, 1002 Scholnick SB, 1676 Sredni B, 1276 Peters LJ, 1308 Rischin D, 1297 Schou G, 128 Srivastava S, 331 Peto R, 1791 Ritenbaugh C, 81 Schroeder G, 1039 St. Croix B, 1285 Petrelli NJ, 1665 Rivenson A, 899 Schwaab G, 1228 Stampfer MJ, 988, 1118, 1375 Phelps J, 81 Ro JY, 519 Schwab D, 1580 Stein CA, 391 Phillips KK, 1731 Roberson KM, 908 Schwaiger M, 1204 Stein U, 1383 Piatyszek M4, 116, 839 Robert-Guroff M, 372 Schwartz SM, 210 Steis RG, 44 Piccirillo JF, 1676 Roberts AB, 123 Sciajno R, 291 Stern TL, 372 Piedbois P, 252 Roberts DR, 1046 Seagren SL, 1210 Stevens MM, 1848 Pienta KJ, 55 Roberts R, 1659 Secreto G, 291 Stillman IE, 1054 Pietinen P, 1560 Robertson CN, 908 Segui J, 1078 Stjernberg N, 1302 Pike MC, 128, 650 Robidoux A, 1529 Seifter EJ, 126, 208 Stoler D, 1665 Pilotti S, 1002 Robison LL, 24 Semjonow A, 1594 Storm H, 128, 727 Pisani P, 291 Rocha RL, 601 Sepkovic DW, 617 Story JA, 81 Plewig G, 802 Roche B, 1228 Serini G, 442 Stoter G, 1393 Pollard M, 56 Roder JD, 1222 Seynaeve C, 1393 Stovali MA, 270 Ponzetto A, 465, 1000 Rodriguez-Bigas M, 1665 Shah KV, 1060, 1068 Strassman G, 1276 Popescu NC, 450 Rogatko A, 462 Sharnanin V, 802 Streicher RP, 1046 Porfirio B, 1865 Rémer W, 1204 Shani A, 1276 Stukel TA, 1848 Porrath SA, 128 Rommel B, 1234 Sharfman WH, 44 Sumizawa T, 1110 1876 AUTHOR INDEX Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 Sun C, i467 Travis LB, 51 Wan M, 510 Workman P, 259, 1161 Sun J, 607 Travis WD, 52 Wang P, 1152 Worland PJ, 956 Sun X-W, 355 Trent JM, 1731 Wang Q, 956 Wright TC, Jr, 355 Sunwoo JB, 1676 Tretli S, 128, 727 Wang Y, 1467 Wright WE, 456 Suzuki M, 467 Trichopoulos D, 883 Wanschura S, 1234 Wu AH, 650 Svingen PA, 734 Trimble EL, 812 Ward AJ, 377 Wynder EL, 183, 377, 1867 Swain SM, 1510 Tross S, 661 Ward EM, 1046 Wynn TT, 899 Swanson CA, 756, 1127 Trusolino L, 442 Ward JH, 872 Swanson GM, 377 Tu ZN, 519 Wargovich MJ, 67 xX Swanson MK, 340 Tucker MA, 1492 Warmerdam PG, 54 Swenson K, 842 Tulinius H, 128 Wasson JH, 166 Synold T, 1495 Tursz T, 1857 Watanabe M, 1240 Xu D, 1467 Sznol M, 44 Twiggs LB, 1127 Waters DJ, 1686 Xue L, 1586 Watson PH, 284 T U Weber W, 1204 Y Webster LK, 1297 Ungerleider RS, 812, 1645 Weed DL, 1698 Tabar L, 52 Urba WJ, 44 Weichselbaum RR, 1764 Yamada K, 1110 Tafur L, 1068 Urcelay B, 198 Weisburger JH, 836 Yamada Y, 1110 Tagliabue E, 1241 Ursin G, 128, 1332 Weiss JE, 1848 Yan M, 1467 Taioli E, 617 Weiss NS, 210, 764 Yang K, 1586 Takahashi K, 686 Vv Weissman BE, 1731 Yang N-S, 607 Takahashi Y, 1146 Welch DR, 1731 Yannelli JR, 100 TTTTTTaaaaaallklknabaeea osbdktkEaaa a,y MaM1Ks,G,5,h G6 i,1076 2 4822Y618 , 0 4161 10 VVVVvaaaaailnilte natninAitiosnis pen HnieB , r, ePA n1,,18 5514J5321,0 8 99 94 WWWWWeeeeelllrnlllsnssstb oe DHSrAABNg,,,, JJ111rE3,64, 978 690381 066 YYYYYYeeaooolernokl be iorndDGyo ,aHau F,m6gJ J0,ha, 1 16 15W7T185,G40 ,6 1 161,4 8893 9 Tangi I, 973 van den Brandt PA, 93, 768 West DW, 650 Young, JL, Jr, 456 Tangrea JA, 1560 van der Maas PJ, 54 Westra WH, 1580 Yu WL, 1000 Tannock IF, 206 van der Ploeg HM, 1478 Whang-Peng J, 1000 Yuan Y, 1317 Taplin SH, 643 van Leeuwen FE, 209, 1759 Whelan T, 1659 TTaarsoknien enR E,E, 11557610 vvaann TPeolplpienlg eGn, O9,3 994 WWhiibtauel tE , P2,1 01,2 2684 3 Z Tattersall MNH, 1331 Varricchio CG, 459 Wickerham DL, 1529 Taube S, 1456 Vasilev SA, 1361 Wieand HS, 1039 Zahurak M, 1580 Taubenberger J, 100 Vaughan TL, 542 Wigginton JM, 38 Zang EA, 183, 764, 899, 1867 Taylor PR, 1560 Velicescu M, 510 Wilbanks GD, 1127 Zatonski W, 727 Teass AW, 1046 Vena JE, 340 Wilczynski SP, 1361 Zequeira MR, 1676 Tejeda HA, 812 Vergara A, 1060 Wilkinson RH, 1659 Zhang L, 1399 Teppo L, 727, 1408, 1560 Verweij J, 1393 Willan A, 1659 Zhang Z, 530 Terz J, 1529 Vidal-Vanaclocha F, 198 Willett WC, 1375 Zhao Z, 899 Thalmann GN, 794 Vikram B, 1779 Williams JH, Jr, 1550 Zheng J. 510 Thomas DB, 542 Viladiu P, 1060 Wilson LMK, 270 Zhu B-P, 841, 1158 Thompson M, 301, 1237, 1592 Villamor J, 303 Wiltrout RH, 38 Ziegler A, 349 Thorban S, 1222 Virtamo J, 1560 Wing A, 1375 Ziegler RG, 612, 650 Thornquist MD, 1550 Vitale V, 583 Wingard DL, 1867 Ziegler S, 1204 Tichler T, 1276 Volkenandt M, 590 Winn RJ, 1456 Zimonjic DB, 450 Tobi H, 530 von Eschenbach AC, 794 Winter DL, 270 Zocchi M, 436, 1242 Toma S, 1494 von Minckwitz G, 1652 Wiseman RW, 552 Zéchbauer S, 1593 Tomita Y, 686 Volker K, 747 Wolff H, 802 Zon G, 419 Toner GC, 1297 Vriesendorp HM, 1405 Wolk A, 1472 Zuna RE, 980, 1779 Tonino P, 198 Wolmark N, 1529 Zupi G, 419 Tormey DC, 668, 1828 Ww Won Y-J, 1317 zur Hausen H, 802 Tortora G, 1770 Wood W, 661 Trachman J, 617 Wahlqvist ML, 378 Woods MN, 1369 Trail N, 1369 Walther W, 1383 Woollett AM, 1297 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 AUTHOR INDEX 1877 Antisense oligodeoxynucleotides, antitumor effects, 391 (editorial), 419 SUBJECT Antitumor effector cells, immunotherapies and gene encoding for, 1639 Apoptosis INDEX p53-mediated, 1449 paclitaxel (mice), 1308 Todaro and De Larco’s hypothesis of tumor growth, revised (cor- respondence), 1239 Aromatic amines, bladder cancer incidence and exposure in a chemi- cal plant, 1046 A AS101 immunoregulator, and T helper, 1276 Asbestos, glutathione S-transferase and N-acetyltransferase genotypes, Abortion, bias, and breast cancer, 1759 (editorial), 1698 and pulmonary disorders, 1853 N-Acetyltransferase, genotype and asbestos-associated pulmonary dis- Asian-Americans, breast cancer and height and weight, 650 orders, 1853 Aspirin, breast cancer risk, 941 (editorial), 988 Adenovirus-mediated gene transfer, lung cancer, 241 Astrocytic tumor, gastrin and cell proliferation, 594 Adhesion molecule expression, levamisole’s effect on colon tumor ATBC Study see Alpha-Tocopherol, Beta-Carotene Cancer Prevention cell line, 109 Study Adolescents, smoking by race, 1158 Atlas of Diagnostic Oncology, second edition (book review), 1076 African Americans Atlas of Surgical Oncology (book review), 127 breast cancer prevention (editorial), 1331 clinical trials, 812 prostate cancer, incidence trends, U.S., 1683 B women, diet change, and hormone levels, 1369 Age Basal cell carcinoma breast cancer care, 701 (editorial), 716 molecular epidemiology (editorial), 315 cancer susceptibility, 503 sunlight and genetic alteration, 349 AIDS, brain lymphoma and, 675 B-cells, non-Hodgkin’s lymphoma, translocation, 973 Alcohol consumption Bcl-2, urinary tract transitional cell cancer, prognosis and (correspon- infant leukemia risk, 24 dence), 686 lung cancer and, 1554 Behavior, BRCA| testing (commentary), 872 Alcoholism, head and neck cancer and, 542 Bias, abortion and breast cancer, 1759 (editorial), 1698 Alkaline phosphatase, ADEPT systems, 158 Bile acids, fecal, wheat bran fiber and calcium, adenomatous colon Alkylating agents polyps, 81 bone cancer following childhood cancers, 270 Biliary tract cancers, risk in diabetes mellitus, 1472 DNA adducts, 1347 repair and resistance, 1352 Biomarkers, head and neck squamous cell carcinoma, 518 secondary AML, 408 Bioregulators, (editorial), 479 (erratum), 1080 All-trans-retinoic acid (ATRA), aleukemic granulocytic sarcoma (cor- Blacks see African American respondence), 1494 Bladder cancer, aromatic amine exposure in a chemical plant, 1046 Alpha-fetoprotein, modernized version of Todaro and De Larco’s Bleeding, diethy|stilbestrol (correspondence), 765 hypothesis of tumor growth (correspondence), 1239 Body mass see Weight Amino acids, branched-chain, oral administration and anorexia and Body size, lung cancer and gender, 183 caloric intake, 550 Bone cancer, radiotherapy, alkylating agents, for childhood cancers, Aminobipheny]l, ladder cancer and, 1046 270 Aminopeptidase, ADEPT systems, 157 Bone marrow AML see Leukemia, acute myelogenous breast cancer, micrometastatic cells vs nodal status for prognosis, Androgens, (serum levels), menopause and subsequent breast cancer, 1652 290 esophageal cancer and disseminated tumor cells, 1222 Androstenedione, endometrial cancer risk, 1027 fibroblast growth factors, protection from radiation with, 1399 Angiogenesis, breast cancer (node negative) survival, 231 G-CSF prechemotherapy and, 1393 Aniline, bladder cancer and, 1046 Book reviews Anorexia, branched-chain amino acids, oral administration and caloric Atlas of Diagnostic Oncology, 2nd edition, 1076 intake, 550 Atlas of Surgical Oncology, 127 Anti-Cancer Treatment, Sixth international Congress on, report (cor- Breast Cancer: A Practical Guide to Diagnosis. Volume 1—Proce- respondence), 686 dures, 683 Antibody-directed enzyme prodrug therapy (ADEPT), 153 Breast Cancer: What Every Woman Should Know, 301 Antibody—enzyme conjugates, 153 Cancer of the Breast, 4th edition, 759 Antigens, cancer regression, genes encoded for, and immunotherapies, Cancer Prevention and Control, 126 1635 Cancer Wars: How Politics Shapes What We Know and Don’t Know Antimetabolites, topotecan interaction and human cancer cell lines, About Cancer, 208 734 Chemical Induction of Cancer: Modulation and Combination Ef- Antimicrotubule agents, topotecan interaction and human cancer cell fects—An Inventory of the Many Factors Which Influence Car- lines, 734 cinogenesis, 836 Antipyrine, impaired hepatic function, 817 Clinical Oncology, 126 1878 SUBJECT INDEX Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 Comprehensive Textbook of Genitourinary Oncology, 924 radiotherapy The Cure of Childhood Leukemia: Into the Age of Miracles, 375 early stage, older women, 716 Early Breast Cancer, 127 following lumpectomy and axillary dissection for node-negativity, Esophageal Surgery, 50 clinical trial, 1659 Finding a Lump in Your Breast: Where to Go . . . What to Do, 1237 reporting bias, and abortion, 1759 (editorial), 1698 Handbook of Cancer Chemotherapy, 4th edition, 555 risk factors, 365 Helping Your Mate Face Breast Cancer: Tips for Becoming an Ef- aspirin, 941 (editorial), 988 fective Support Partner, 1591 diet and, 340 Hematology: Basic Principles and Practice, 2nd Edition, 126 estimation methods, 1315 No Less a Woman: Femininity, Sexuality and Breast Cancer, 2nd family history, 365 (correspondence), 1003 edition, 459 screening trials interpreted (correspondence), 52 Oxford Textbook of Oncology, 616 surgery, early stage, older women, 716 Systemic Radiotherapy With Monoclonal Antibodies: Options and susceptibility, 754 Problems, 1405 tamoxifen (correspondence), 210 Thoracic Surgery, 50 early stage, 2 vs 5 years, 1543 Waking Up, Fighting Back, 1777 node-negative, estrogen receptor-positive tumors, 5 vs >5 years, Brain lymphoma, with or without AIDS, 675 1529 BRCAI telomerase activity (correspondence), 839 ovarian cancer, detected by protein truncation test, 552 second cancers, 832 (correspondence), 1496 testing, behavioral and psychosocial effects (commentary), 872 tumor marker-immunostaining intensity, 1054 BRCA2 (correspondence), 1408 wheat bran and psyllium diets (rats), 899 Breast Breast Cancer: A Practical Guide to Diagnosis. Volume 1—Proce- tumors and telomerase, 116 dures (book review), 683 estrogen receptor variants in normal human tissue, 284 Breast Cancer: What Every Woman Should Know (book review), 30! Breast cancer Burkitt’s lymphoma, EBV and (commentary), 1438 abortion and bias, 1759 (editorial), 1698 axillary lymph node involvement, PET using F-18 FDG, 1204 c-erbB-2 alteration (correspondence), 1002 C chemoprevention (rats), 123 DNA repair and, 754 cagA status, Helicobacter pylori and atrophic gastritis (correspon- elderly, care for the, 701 (editorial), 716 dence), 1000 estrogen-independent, c-myc and tamoxifen-induced apoptosis, 279 cagA, Helicobacter pylori and atrophic gastritis (correspondence), 465 fat (dietary) and, measurement error and results from analytic Calcium (dietary) epidemiology, 1738 colorectal cancer among women, 1375 fatty acids (dietary) during pregnancy (rats), 1821 colon cancer, 67 (editorial), 81 fiber and (editorial), 857 epithelial cell hyperproliferation in exocrine pancreas (mice), 1586 G-CSF prechemotherapy and bone marrow, 1393 Caloric intake, branched-chain amino acids, oral administration and height and weight in Asian-Americans, 650 anorexia, 550 hyaluronidase and drug resistance, 1285 Cancer and Leukemia Group B (CALGB) trial IL-10 and tumor growth (mice), 536 breast cancer outcome and psychological predictors, 661 incidence, survival, and mortality, 1571 lung cancer, non-small-cell, survival in stage III, 1210 insulin-like growth factor-binding protein-3 messenger RNA and Cancer of the Breast, 4th edition (book review), 759 prognosis, 601 Cancer Prevention and Control (book review), 126 log-incidence model, 359 Cancer Wars: How Politics Shapes What We Know and Don’t Know micrometastatic cells in bone marrow at primary surgery vs nodal About Cancer (book review), 208 status for prognosis, 1652 Carboxypeptidase A, ADEPT systems, 157 node-negative Carboxypeptidase G2 (CPG2), ADEPT systems, 156 angiogenesis and survival, 231 Carcinogenesis, mechanisms, 498 estrogen receptor-positive tumors, tamoxifen, 5 vs >5 years, 1529 Carcinogens, smoking-related and their metabolism, 23D preliminary results from the Cancer Research Campaign trial CARET see Beta-Carotene and Retinol Efficacy Trial evaluating tamoxifen duration in women aged 50 years or older a-Carotene, lung cancer and, 612 with, 1834 6-Carotene p53 ATBC Study, 1560 alteration (correspondence), 1002 CARET, 1550 immunostaining intensity and (editorial), 1015 colorectal cancer (correspondence), 377 prognosis, 141 (editorial), 173 (correspondence), 1499 lung cancer and, 612, 1513 (editorial), 1550, 1560 personality factors and, 1478 Carotenoids Pike model, 365 breast cancer risk, 340 postmenopausal ovarian cancer and serum micronutrients, 32 early stage, tamoxifen for 2 vs 5 years, 1543 Catalytic antibodies, ADEPT systems, 162 node-positive, postchemotherapy adjuvant tamoxifen therapy 6-Catenin, immunotherapies and gene encoding for, 1638 beyond 5 years in patients with, 1828 CDKN2 sex hormones (serum levels), 291! mutation, and ductal pancreatic adenocarcinoma, 680 prevention in African-American women (editorial), 1332 familial tumor syndrome and, 1489 psychological distress and disease course, 629 (editorial), 661 Cecum, irinotecan and (mice) (correspondence), 1240 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 SUBJECT INDEX 1879 Cell adhesion, myeloid levamisole’s effect on colon tumor cell line, minorities (correspondence), 377 109 phase II false positive, false negative (correspondence), 462 c-erbB-2, breast cancer and alteration (correspondence), 1002 prostate cancer, relapsed, 1623 Cervical cancer prostate-specific antigen (editorial), 779 control (editorial), 317 racial representation, 812 human papillomavirus c-myc HPV 18 and prognosis, 1361 oligodeoxynucleotides, antitumor effects, 391 (editorial), 419 male sexual behavior, Colombia, 1068 tamoxifen-induced apoptosis in estrogen-independent breast cancer male sexual behavior, Spain, 1060 cells, 279 type and squamous intraepithelial lesions, 355 Cognition, determinants of survival in older patients, 1031 intraepithelial neoplasia (CIN) (editorial), 317 Colombia, cervical cancer, male sexual behavior and human papillo- peritoneal cytology (editorial), 939, 980 (correspondence), 1779 mavirus DNA, 1060 prognosis (editorial), 1331 Colon cancer screening (editorial), 317 clinical trials, 1646, 1648 screening North Carolina Cherokee, and health education, 1670 diet, 67 (editorial), 81 Chemical exposure, bladder cancer and, 1046 levamisol and fluorouracil, ana inflammatory bowel disease (corre- Chemical Induction of Cancer: Modulation and Combination Ef- spondence), 303 fects—An Inventory of the Many Factors Which Influence Car- multidrug resistance, reversal by transduction of cytokine genes, 1383 cinogenesis (book review), 836 platelet-derived endothelial growth factor and angiogenesis, 1146 Chemoprevention, mammary carcinogenesis (rats), 123 Colon tumor (cell line), levamisole and, 109 Chemotherapy Colorectal adenoma head and neck squamous cell carcinoma, alternating with diet and (correspondence), 377 radiotherapy, vs radiotherapy alone, 582 smoking and, 1717 DNA adducts, 1346 Colorectal cancer Chemotherapy calcium and vitamin D among women, 1375 drug resistance and DNA repair, 1350 fluoropyrimidines and (6R,S) leucovorin (rats), 430 FUDR with HAI vs IVS, 252 fluorouracil administration (bolus vs infusion) with or without cispla- head and neck cancer (editorial), 855 tin, 668 head and neck squamous cell carcinoma, clinical trial (correspon- genetic screening, NCI workshop (commentary), 331 dence), 1407 hepatic arterial infusion for nonresectabie liver metastases (corre- non-small-cell lung cancer, unresectable stage III (editorial), 1175 spondence), 838 primary, head and neck cancer, advanced (editorial), 567 hereditary nonpolyposis radiosensitizing nucleosides, 1193 hMLH1I and 2 genes, Korea, 1317 synergy (editorial), 699 molecular mechanisms, 240 Cherokee, North Carolina, health education and cervical cancer liver metastases and hepatic arterial infusion, 252 screening, 1670 smoking and Childhood cancers trends, 1717 acute myeloid leukemia relapse, prediction by flow cytometry, 1483 Sweden, 1302 bone cancer following radiotherapy and alkylating agents, 270 sporadic, p53 tumor suppressor gene status and the degree of China, esophageal cancer and HPV 16, 1467 genomic instability, 1665 Chlamydia trachomatis, cervical cancer risk factors, Colombia, 1060 thymidine phosphorylase and prognosis, 1110 Chloroethyinitrosoureas (CENUs) Combined-action terms (editorial), 699 DNA adducts, 1347 Comprehensive Textbook of Genitourinary Oncology (book review), repair and resistance, 1352 924 Cholecystokinin (CCK), astrocytic tumor cell proliferation, 594 Counseling Chromosomes see also X Chromosome BRCA|I testing (commentary), 872 3(p14), Kaposi’s sarcoma, 450 prostatectomy, 139 6p21, breakpoints, pulmonary chondroid hamartomas, 1234 Cremophor, pharmacokinetics, with infusions of paclitaxel, 1297 allelic loss and outcome in squamous cell carcinoma of the supra- The Cure of Childhood Leukemia: Into the Age of Miracles, (book glottic larynx, 1676 Cigarette smoking see Smoking review), 375 Cisplatin CWR22 xenograft, prostate cancer gene therapy, 607 colorectal cancer, 668 Cyclin D1, drug sensitivity in human fibrosarcoma cell line, 1255 topotecan interaction and human cancer cell lines, 734 (editorial), 1269 Clinical Oncology (book review), 126 Cysteine, ovarian tumors (rats), 193 Clinical trials Cytarabine, drug sensitivity in human fibrosarcoma cell line, 1255 breast cancer, irradiation following lumpectomy and axillary dissec- (editorial), 1269 tion for node-negativity, 1659 Cytokines, see also Interleukin confirmatory randomized, 1606 (editorial), 1645 gene transduction into colon carcinoma cells to reverse multidrug false-positive results, 206 resistance, 1383 head and neck squamous cell carcinoma, radiotherapy and chemo- Cytosine deaminase, ADEPT systems, 162 therapy, 582 (correspondence), 1407 Cytotoxicity interpretation, 1647 synergy (editorial), 699 larynx preservation in pyriform sinus cancer, 890 drug sensitivity in human fibrosarcoma cell line, 1255 (editorial), lung cancer, non-small-cell, survival in stage III, 1210 1269 1880 SUBJECT INDEX Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 D Epidemiology, breast cancer and dietary fat, measurement error and results, 1738 Denmark Epithelial cell hyperproliferation, exocrine pancreas, induced by prostate cancer (correspondence), 128 Western-style diet (mice), 1586 testicular cancer incidence, 727 Epstein-Barr virus vaccines (commentary), 1436 Developmental sequence, prostate cancer, 1630 Errata Dexamethasone, hypersensitivity reactions and paclitaxel (correspon- “Bioregulators Come of Age in the Control of Tumor Growth and Metastasis,” by Nicolson [J Natl Cancer Inst 1996;88:479-80 dence), 463 Diabetes mellitus, liver and biliary tract cancer risk, 1472 (Issue 8)], 1080 Diagnosis “Human Lung Carcinogen-DNA Adduct Levels Mediated by determinants of surviva! in older patients, 1031 Genetic Polymorphisms In Vivo,” by Kato et al. [J Natl Cancer molecular, 1447 Inst 1995; 87:902-7 (Issue 12)], 1595 Diet “Reduction of Oncoprotein Transformation In Vitro by Albumin,” breast cancer risk, 340 Correspondence by Raju et al. [J Natl Cancer Inst 1996;88:556-7 change and hormone levels in African-American women, 1369 (Issue 8)], 769 : colorectal cancer, 377 (correspondence), 1375 Esophageal cancer ‘ pancreas, exocrine, and epithelial cell hyperproliferation (mice), bone marrow and disseminated tumor cells, 1222 ; 1586 HPV 16 and, 1421 (editorial), 1467 § prostate cancer (mice) (correspondence), 56 Esophageal Surgery (book review), 50 Diethylstilbestrol Estradiol, prostate cancer risk and, 1118 prostate cancer cells, 908 Estrogen diet change and, African-American women, 1369 uncontrolled bleeding in cancer (correspondence), 765 DNA endogenous, and body mass in menopause, 756 alkylating agents, topotecan interaction and human cancer cell lines, menopause and subsequent breast cancer, 290 734 metabolism, ethnicity and (correspondence), 617 damage receptor-negative cancers, tamoxifen (editorial), 225 apoptotic response pathways, p53 and, 1442 receptors, variants in normal human m><:imary tissue, 284 -inducible repair and resistance, 1353 replacement therapy (ERT), mammography and, 627 (editorial), 643 repair and leukemogenesis, 409 Ethnicity, see also Race, estrogen metabolism, and (correspondence), 617 recombination, leukemia cells, etoposide, cytotoxicity and site- specificity, 1840 Etoposide, leukemia cells, cytotoxicity and site-specific DNA recom- repair bination, 24G breast cancer and, 754 Europe, testicular cancer incidence, 727 enzymatic mechanisms and drug response, 1346 Ewing’s sarcoma, validation of cancer in deceased family members, 1492 sequencing, complementary vs immunohistochemistry, breast cancer prognosis and, 173 Docetaxel treatment, typhlitis and (correspondence), 1078 F Dogs, prostate cancer, age at diagnosis (correspondence), 1686 Doxorubicin False-positive results, clinical trials, 206 drug sensitivity in human fibrosarcoma cell line, 1255 (editorial), Familial tumor syndrome, pl6lNK4a tumor suppressor gene, 1489 1269 Family history MRP/GS-X pump (correspondence), 466 Drug resistance, breast cancer and hyaluronidase, 1285 breast cancer, 365 (correspondence), 1003 validation of cancer in deceased family members, 1492 Drug sensitivity, regulatory genes and, 1255 (editorial), 1269 Fat (dietary) DT-diaphorase, NCI cell lines, 259 breast cancer and, measurement error and results results from analytic epidemiology, 1738 colorectal cancer (correspondence), 377 E epithelial cell hyperproliferation in exocrine pancreas (mice), 1586 Fatty acids, dietary, during pregnancy, and breast cancer (rats), 1821 EO9, reductase enzyme expression in NCI cell lines (correspondence), Fiber (dietary) 259, 1161 breast cancer and, 340 (editorial), 857 Early Breast Cancer (book review), 127 colorectal cancer (correspondence), 377 E-cadherin, thyroid cancer, 442 diet and colon cancer, 67 (editorial), 81 Education mammary cancer (rats), 899 cervical cancer screening, Cherokee, North Carolina, 1670 Fibrosarcoma cell line, drug sensitivity and cyclin D1, 1255 cervical cancer risk factors, Colombia, 1060 (editorial), 1269 determinants of survival in older patients, 1031 Finding a Lump in Your Breast: Where to Go . . . What to Do, (book smoking and (correspondence), 840 review), 1237 Elderly, breast cancer care, 701 (editorial), 716 Finland Endometrial cancer lung cancer risk and radon exposure, 966 endogenous steroid hormones and, 1027 ovarian cancer and selenium (correspondence), 1408 peritoneal cytology (editorial), 939 (correspondence), 980, 1779 pulmonary disorders, asbestos and glutathione S-transferase and N- tamoxifen therapy and (correspondence), 210 acetyltransferase genotypes, 1853 Environmental factors, molecular epidemiology and, 496 testicular cancer incidence, 727 Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996 SUBJECT INDEX 1881 Flavonols, cancer risk and, 93 Glutathione S-transferase, genotype and asbestos-associated pul- Flow cytometry, pediatric acute myeloid leukemia relapse prediction, monary disorders, 1853 1483 Glycosidases, ADEPT systems, 158 Floxuridine (FUDR), HAI vs IVC, 252 gp100, immunotherapies and gene encoding for, 1636 Fludarabine, radiosensitization, 1198 Grading system (editorial), 1419 2-(Fluorine-18)-fluoro-2-deoxy-D-glucose, axillary lymph node involve- Granulocyte colony-stimulating factor (G-CSF), prechemotherapy ment in breast cancer, 1204 and bone marrow, 1393 Fluoropyrimidines Granulocytic sarcoma, aleukemic, (correspondence), 1494 biochemical modulation (editorial), 393 Growth factor receptor, epidermal, protein kinase A and, for an- colorectal carcinoma (rats), 430 titumor activity, 1770 radiosensitization, 1193 Growth factors Fluorouracil -binding protein-3, insulin-like, messenger RNA, breast cancer prog- administration (bolus vs infusion) in colorectal cancer, 668 nosis and, 601 colon cancer, and inflammatory bowel disease (correspondence), 303 fibroblast, myeloprotective doses and tumor growth and radiosen- Folic acid sitivity (mice), 1399 breast cancer risk, 340 platelet-derived endothelial, colon cancer angiogenesis, 1146 lometrexol toxicity and (correspondence), 1495 Gynecologic cancer, peritoneal cytology, 939 (editorial), 980 (corre- Fruits, breast cancer risk, 340 spondence), 1779 Fusion proteins, ADEPT systems, 162 H G Handbook of Cancer Chemotherapy, 4th edition (book review), 555 HBL-100 cell lines, Mason—Pfizer monkey virus, 372 G2, UCN-01 and function, 956 Head and neck cancer Gastrin, astrocytic tumor cell proliferation, 594 advanced, primary chemotherapy (editorial), 567 Gastritis, atrophic alcoholism and, 542 Helicobacter pylori and (correspondence), 762 Bcl-2 overexpression and smoking history in, 1864 Helicobacter pylori and cagA (correspondence), 465 (correspon- induction chemotherapy (editorial), 855 dence), 1000 radiotherapy and neuropathy following paclitaxel (correspondence), Gastrointestinal cancer, tamoxifen and (correspondence), 1496 1000 Gemcitabine, radiosensitization, 1198 squamous cell carcinoma Gender genetic susceptibility, 530 cancer susceptibility, 504 p53 mutation and treatment failure, 1580 lung cancer risk (correspondence), 764 p53 serum antibodies, 1228 Gene therapy p53 to predict recurrence and second primary tumors, 518 p53 and, 1449 radiotherapy alternating with chemotherapy compared with prostate cancer, and CWR22 xenograft model for, 607 radiotherapy alone, 582 (correspondence), 1407 Genes see also particular gene supraglottic larynx, chromosome 8 allelic loss and outcome, 1676 cancer susceptibility, 500 vinorelbine and acute tumor pain (correspondence), 1593 colorectal cancer, hMLH1 and 2 in hereditary nonpolyposis, Korea, Health education, cervical cancer screening, North Carolina Cherokee, 1317 1670 colorectal cancer, smoking and, 1717 Height, weight and breast cancer in Asian-Americans, 650 colorectal cancer screening, NCI workshop (commentary), 331 Helicobacter pylori, atrophic gastritis and (correspondence), 762 colorectal carcinoma, heriditary nonpolyposis, 240 cagA status (correspondence), 465 (correspondence), 1000 cytokine, transduction into colon carcinoma cells to reverse multi- Helping Your Mate Face Breast Cancer: Tips for Becoming an Ef- drug resistance, 1383 fective Support Partner (book review), 1591 encoding cancer regression antigens, immunotherapies and, 1635 Hemangiopericytoma, interferon & (correspondence), 764 mdrla, Pgp deficiency and vinblastine pharmacokinetics (mice), 994 Hematology: Basic Principles and Practice, 2nd editon, (book metastasis-suppressors, 1731 (editorial), 1700 review), 126 “<r tumor suppressor, familial tumor syndrome and, 1489 Hepatic artery infusion pulmonary chondroid hamartomas, HMG-I(Y) and chromosome clinical and economic trade-offs, 223 (editorial), 252 6p21 breakpoints, 1234 nonresectable liver metastases from colorectal cancer (correspon- regulatory and drug sensitivity, 1255 (editorial), 1269 dence), 838 repair, expression in resistant cell lines, 1354 Hepatitis C virus, hepatocellular carcinoma among Japanese, 742 skin cancer, basal cell carcinoma and sunlight, 349 Hispanics, clinical trials, 812 transfer, adenoviral-mediated, lung cancer, 1857 Histocompatibility complex, major, levamisole’s effect on colon Genomic instability tumor cell line, 109 cancer and (editorial), 1608 History, validation of cancer in deceased family members, 1492 p53 tumor suppressor gene status and, sporadic colorectal cancers, HNPCC see Colorectal carcinoma, heriditary nonpolyposis 1665 Hodgkin’s disease Genotoxic lesions, repair, 1347 EBV and (commentary), 1439 Germany, testicular cancer incidence, 727 lung cancer (correspondence), 51 ¥-Glutamyl transpeptidase, glutathione and, ovarian tumors (rats), treatment, smoking, and lung cancer risk (correspondence), 209 193 Hormones 1882 SUBJECT INDEX Journal of the National Cancer Institute, Vol. 88, No. 24, December 18, 1996

See more

The list of books you might like

Upgrade Premium
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.
DMCA & Copyright: Dear all, most of the website is community built, users are uploading hundred of books everyday, which makes really hard for us to identify copyrighted material, please contact us if you want any material removed.
Copyright @ PDFdrive.to, 2022 | We love our users